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One of the backbones in nanomedicine is to deliver drugs specifically to unhealthy 
cells. Luminescent inorganic mesoporous silica nanoparticles (QDs@mSiO2) are a new 
generation of nanocarriers acting as all-in-one diagnostic and therapeutic tools due to their 
excellent biocompatibility, biodegradability and high surface area.  
Among all fluorescent agents, quantum dots have been widely used due to their 
high luminescence quantum yields and great optical properties. Based on such facts, herein 
we present a synthesis of Cadmium Telluride and Silicon quantum dots under mild 
conditions, in water and in open air conditions. These quantum dots were further 
functionalized with a layer of mesoporous silica nanoparticles.  
In order to increase the solubility of these systems in water, a derivative of 
poly(ethylene glycol) (PEG) was added to their surface. Specifically, three types of               
PEG-derivatives were synthesized, having three different PEG-chain lengths with (i)           
MW 3000, (ii) MW 6000, and (iii) MW 8000. The nanoparticles were characterized by 
different techniques (TEM, SEM, DLS, FT-IR, absorption and emission spectroscopy), 
showing high surface area, an effective coating of the mesoporous silica nanoparticles with 
the PEG layer, and also improved monodisperse suspension in water in comparison with 
the unfunctionalized nanoparticles. The behavior of these nanoparticles was investigated at 
physiological pH (PBS, pH = 7.4) with single proteins exhibiting different sizes and pI, with 
the aim of gaining new insights regarding the encapsulation efficiency of these 
nanoparticles with proteins.  

















Uma das principais dificuldades em nanomedicina tem sido a administração de 
fármacos, especificamente em células não saudáveis. As nanopartículas inorgânicas 
luminescentes de sílica mesoporosa (QDs@mSiO2) são uma nova geração de nano-                          
-transportadores que atuam como ferramentas de diagnóstico e terapia "tudo em um" 
devido à sua excelente biocompatibilidade, biodegradabilidade e elevada área de superfície. 
Entre todos os agentes fluorescentes, os quantum dots têm sido amplamente 
utilizados devido aos seus altos rendimentos quânticos de luminescência e excelentes 
propriedades óticas. Tendo isso em conta, apresentam-se as sínteses de quantum dots de 
Cádmio Telúrio e Silício, realizadas em condições suaves, em água e em condições 
atmosféricas. Posteriormente, estes quantum dots foram funcionalizados com uma camada 
de nanopartículas de sílica mesoporosa.  
De forma a aumentar a solubilidade destes sistemas em água, foi adicionado na sua 
superfície um derivado de poli(etilenoglicol) (PEG). Especificamente foram sintetizados 
três tipos de derivados de PEG, possuindo estes, cadeias com diferentes comprimentos (i) 
MM 3000, (ii) MM 6000 e (iii) MM 8000. As nanopartículas foram caracterizadas por 
diferentes técnicas (TEM, SEM, DLS, FT-IR, espectroscopia de absorção e emissão), 
apresentando elevada área de superfície, um revestimento eficaz das nanopartículas de 
sílica mesoporosa com a camada de PEG e uma melhoria na monodispersão da suspensão 
em água em relação às nanopartículas não funcionalizadas. O comportamento destas 
nanopartículas foi investigado em pH fisiológico (PBS, pH = 7.4) com proteínas de diferentes 
tamanhos e pI, com o objetivo de obter novos conhecimentos sobre a eficiência de 
encapsulamento destas nanopartículas com proteínas.  
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1.1. Luminescent Quantum Dots 
1.1.1. Cadmium Telluride Quantum dots (CdTe QDs) 
Quantum dots (QDs), also known as semiconductor nanocrystals (NCs) are a group 
of inorganic nanomaterials that present remarkable optical and electronic properties and 
possess distinct advantages over the traditional fluorescent organic dyes in terms of tunable 
broad excitation and narrow emission spectra, high fluorescence efficiency, large effective 
Stokes shift, long fluorescence lifetime and composition/size-tunability [1]. 
Cadmium is known to be one of the major components in the majority of quantum 
dots, which conjugated with telluride provides bright emission across the visible and         
near-infrared regions of the electromagnetic spectrum, Figure 1.1. However, CdTe QDs are 
known to be extremely toxic to cells and organisms [2,3]. Therefore a less toxic source for 





Figure 1.1 - Normalized emission spectra of CdTe QDs at different excitation wavelengths (adapted 













Concerning the synthesis of CdTe QDs, several methods have been developed, such 
as selective photochemical etching [5,6], ultrasonic irradiation [7] and microwave 
irradiation [8,9]. The aqueous synthetic approach, as a green alternative, compared with the 
others, is relatively simpler, cheaper, less toxic, and more environmentally friendly, end as 
a result has gained a lot of interest in research. Furthermore, the products often show 
improved water-stability and biological compatibility [10]. In addition, in most aqueous 
syntheses of CdTe QDs, an inert atmosphere was necessary during the synthesis due to the 
sensitivity of the tellurium precursor (H2Te or NaHTe) [11]. However previous reported 
studies revealed that using thioglycolic acid (TGA) as ligand and K2TeO3 is possible to 
synthesize CdTe nanocrystals without the protection of nitrogen gas [11]. Subsequently, in 
this presented work, a simple and more friendly method was used to prepare highly 
luminescent water-soluble CdTe QDs using TGA as ligand without nitrogen gas atmosphere, 
when using Na2TeO3 as a stable Te source, and NaBH4 as reducing agent.  
1.1.2. Silicon Quantum Dots (Si QDs) 
As previously said, the commonly used QDs are cadmium based, and their toxicity 
is still a problem in biological applications [12,13]. Silicon (Si) is a well-studied material in 
the semiconductor family, which have attracted great attention due to their intrinsic 
advantages, such as low cost, strong fluorescence, high stability, and photostability. In 
addition, Si QDs exhibit unique abilities such as low toxicity, favorable biocompatibility, and 
biodegradability, which make them widely accepted as promising alternatives to the toxic 
heavy-metal CdTe QDs. Therefore, Si QDs exhibit a significant potential in the biological field 
[14-16]. 
So far different methods of synthesis have been reported, including ultrasonic 
dispersion of electrochemically etched silicon [17], laser-driven pyrolysis of silane [18,19], 
gas phase synthesis [20], microemulsion synthesis [21], among others. However, in order 
to have application in biological systems, Si QDs have to be water-soluble. Recently, He et 
al. introduced an aqueous synthetic method to prepare fluorescent Si QDs under microwave 
irradiation at 160°C [22]. He et al. further developed a photochemical strategy capable of 
large-quantity synthesis of Si QDs under UV irradiation [23]. Li et al. reported the fabrication 
of ultrabright water-dispersible Si QDs through a designed chemical surface modification 
[24]. Wang et al. also reported a method for one-step synthesis of water-dispersible Si QDs 
for time-resolved imaging of living cells [25]. And more recently, Ma et al. developed a       
one-step synthesis of water-dispersible and biocompatible Si QDs for selective heparin 
sensing and cell imaging [26]. According to these previous studies, in this report, Si QDs 
were performed accordingly with ref. [25], and several optimizations were required to 
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create a simple one-step synthesis of water-dispersible Si QDs using                                                                            
(3-aminopropyl)trimethoxysilane (APTMS) and sodium ascorbate (SA) at 50°C for 2 h.  
 
1.2. Luminescent Mesoporous Silica Nanoparticles  
1.2.1. MCM-41 
In 1992, researchers at Mobil Corporation discovered a new generation of 
materials with ordered mesoporous structure, which are aluminosilicates synthesized by 
surfactant micellar arrangements that originate pores of 30–100 Å diameter [27,28]. Within 
this family MCM-41 (Mobil Crystalline Materials No 41) is one of the most used materials as 
support [29,30]. Its structure is based essentially on a cylindrical tube aggregate on 
amorphous silica in a hexagonal arrangement of one-dimensional mesoporous with 
diameters ranging from 2 nm to 5 nm, having a high specific surface area (≈ 1000 m2g-1) and 
a meaning volume pore (≈ 1 cm3g-1) [28]. 
 
Scheme 1.1 – Synthetic procedure of MCM-41 (adapted from ref. [31]). 
 
This material is thermally stable up to 650°C. The inner surface of the MCM-41 
contains nucleophilic Si-OH groups that allow organometallic or inorganic compounds to be 
immobilized by various methods [29,30]. 
In the synthesis, cetyltrimethylammonium bromide (CTAB) is the cationic 
















the silica precursor, and alkali as catalyst [27,32]. When the concentration is above the 
critical micelle concentration (CMC), the surfactant of CTAB would self-aggregate into 
micelles. Around the polar head region of the micelles, the silica precursors condensate at 
the surface of the surfactant and form a silica wall around the surface of the micelles. After 
removal of the surfactant, MCM-41 type mesoporous silica nanoparticles are obtained, 
Scheme 1.1. 
1.2.2. QDs coated with mesoporous silica nanoparticles (MSNs/mSiO2) 
As previously discussed, inorganic QDs possess unique properties that make them 
suitable for several applications. However, its photoinstability is a disadvantage, and with 
time promotes their degradation and agglomeration. One key promising approach for this 
problem, is functionalization of QDs with MSNs, providing a better physical and chemical 
stability of the QDs [33], Scheme 1.2.  
 
Scheme 1.2 – Synthetic procedure of QDs coated with MSNs. 
 
The MSNs are considered to be one of the most powerful mesoporous structures 
as it generally possesses good bio-compatibility and ability to modify its surface, providing 
reservoirs for loading various functional molecules as a nanocarrier, and active sites for 
linking other targeted molecules by covalent associating [34]. As for the QDs, their 
luminescence provides an easy way to track the nanocarriers into the cells. Therefore, QDs 
functionalized with MSNs may not only prevent QDs agglomeration and resolve the 
instability problem, but also offer the quantum confinement effect to take advantage of the 
superior properties of both QDs and MSNs [35]. On the other hand, the drawback is the low 
solubility of these systems with a high polydispersity index (PDI) for in vitro and in vivo 
applications. Consequently, is needed a polymer functionalization of the MSNs surface in 
order to increase the water solubility. 
The encapsulation of inorganic QDs with MSNs has been widely investigated, and 
the methods can be grouped into two general categories, by coating the inorganic QDs with 
MSNs or by introducing the QDs into the pores of the MSNs (dye-doping).  








So far, a number of papers have reported the successful preparation of                   
silica-coated QDs. Wolcott et al. exploited the grow of an amorphous silica shell onto              
as-synthesized water-soluble CdTe QDs functionalized with thiols for bioconjugation to 
immunoglobulin-G-type proteins [36]. Song et al. further demonstrated the fabrication of 
mesoporous CdTe/ZnO@SiO2 core/shell nanostructures with tunable dual emission and 
ultrasensitive fluorescence response to metal ions [37]. Hu et al. also synthesized a new 
generation of silica encapsulated singles quantum dots [38]. And more recently, Zhou et al. 
fabricated mesoporous silica-coated CdTe QDs functionalized with folic acid for targeted 
lung cancer cell imaging [39].  
Techniques such as electrostatic interactions, ligand exchanges, electrophoretic 
deposition, chemical vapor or bath deposition, have been developed for introducing QDs 
into the pores using mesoporous material as templates [40]. Wang et al. synthesized CdSe 
nanoparticles into the pores of mesoporous silica microspheres via direct reaction at low 
temperatures between selenosulfate and (noncomplexed) Cd ions bound to the Si-OH of the 
mesoporous silica microspheres [40]. Sha et al. further reported a method for fabricating 
CdTe functionalized MSNs loaded with conjugated polymers: a facile sensing platform for 
cupric (II) ion detection in water through fluorescence resonance energy transfer [41]. And 
more recently, Gao et al. focused on a simple approach to immobilize Ag NPs onto CdTe QDs 
embedded mesoporous silica nanospheres to prevent bacteria invasion for enhanced 
anticounterfeit applications [42], and Santos et al. created a successful aqueous route to 
grown stable CdTe nanocrystals in situ in thiol-modified MCM-41 mesoporous silica for 
electrochemical detection of Cu2+ [43]. 
Taking in consideration these previous studies, in this report, were performed the 
encapsulation of the inorganic QDs by coating the QDs with MSNs type MCM-41, performing 
the addition of the MSNs to the crude solution of inorganic QDs, in an aqueous synthesis. 
 
1.3. Functionalization of MSNs with biocompatible and biodegradable 
polymers 
1.3.1. PEG, PGLA 
To increase water solubility and biocompatibility, and to reduce undesired 
interactions between the biological environment and the nanocarriers, the mesoporous 
nanoparticles can be functionalized with soft organic macromolecules such as dendrimers 
[44] or phospholipids [45-47]. In particular, the functionalization of the outer surface with 
poly(ethylene glycol) (PEG) and poly(lactic-co-glycolic acid) (PLGA) was developed            
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[48- 51]. For this purpose, these soft organic macromolecules also called polymers, must be 
non-toxic, biodegradable, and biocompatible.  
PEG is a non-ionic hydrophilic polyether 
synthesized by polymerization of the monomer 
ethylene glycol and it can be obtained with a wide 
range of molecular weight from 300 Da to                
100 000 Da, Figure 1.2. PEG is known to be 
commonly utilized in medicine such as an oral laxative, in drugs formulation as excipient, 
and in capsules preparation as coating agent [52]. Due to its hydrophilicity and ability to 
inhibit opsonization, PEG is considered to be profoundly attractive for biological 
applications such as drug delivery, as it can be used to stabilize nanoparticles in aqueous 
media and increase solubility. Moreover, as PEG is a non-ionic polymer, no problems occur 
when it enters in contact with charged biological molecules such as DNA [53,54]. 
PLGA is a synthetic copolymer obtained 
by random ring opening copolymerization of two 
cyclic dimers of lactic and glycolic acid, which are 
linked together by ester linkage in an occasional 
order during copolymerization, creating an 
aliphatic linear polyester [55], Figure 1.3. 
Contrary to PEG, PLGA is known for its biodegradability in aqueous media, that 
occurs when the ester linkage presented in the polymer chain is subjected to hydrolytic 
degradation, and also for is extreme biocompatibility and mechanic strength [56,57]. 
1.3.2. Different methods of synthesis of PEG-derivatives 
An increasing variety of mono-, homo- and heterobifunctional PEG reagents is 
commercially available, with different functional groups, molecular weights and multiple 
arms [58]. However, as described in previous studies, there are several methods to 
synthesize PEG-derivatives, being the major route by nucleophilic substitution on reactive, 
electrophilic PEGs, such as chloride, bromide, tosylate, mesylate or one of the active forms 
of PEG carboxylic acid [59]. Numerous functionalities can be introduced as end groups on 
PEG in this manner, including heterobifunctional products. For instance, Kataoka et al, 
synthesized a heterobifunctional PEG derivative containing aldehyde and thiol end groups 
[60]. Li and Kao, synthesized a library of 50 PEG-derivatives to expand the extent of 
conjugation with biologically active molecules and biomaterial substrates [61]. Hirsch et al, 
synthesized monofunctional PEG molecules, with a methoxy group at the free end [62]. 
Figure 1.2 – Chemical structure of PEG. 
Figure 1.3 – Chemical structure of PLGA. 
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Jayagopal et al, used bifunctional PEG molecules to introduce new functional groups on the 
surface, like with bifunctional crosslinkers in conjugation chemistry [63]. And more 
recently, Cauda et al, synthetized a well-known PEG-derivative, PEG-silane, commonly used 
in the functionalization of nanoparticles surface to increase water solubility [64]. Its 
synthesis generally consists in the formation of an intermediate leaving group, for example 
PEG tosylane, following the combination with (3-aminopropyl)triethoxysilane (APTES), 
creating the linear PEG-Silane [64]. 
 
1.4. Use of luminescent MSNs for drug/or proteins encapsulation 
MSNs have particular properties which include large pore volume and high surface 
area, tunable particle size (10-1000 nm) and pore diameter (2-30 nm), uniform porosity, 
flexible morphology, easy surface functionalization, excellent biocompatibility and 
biodegradation. As a result, MSNs have been widely applied in the fields of separation and 
absorption [65], providing the possibility to load a high number of drugs or proteins within 
MSNs nanocarriers. In particular, the unique properties of these silica materials give them 
substantial potential for size exclusion separations of large molecules such as proteins 
[66,67]. On the other hand, these MSNs possess on their mesoporous channels surfaces and 
in the outer surfaces, several silanol groups, which facilitates the functionalization of the 
surface to allow a better control over the drug/protein diffusion kinetics, and also 
enhancing their selective absorption of several proteins with different molecular weights 
(MWs) or isoelectric points (pI), based on the exclusion mechanism [65]. In addition, 
functional materials, such as luminescent materials and polymers, can be combined with 
MSNs to form functional MSNs, which allow them to realize a targeted controlled 
drug/protein delivery and/or imaging. Therefore, MSNs have been considered to be 
excellent candidates as nanocarriers for drug/protein delivery [68-73]. 
Recently, many efforts have been made in the structural design and functional 
optimization to advance the development of drug/protein delivery systems based on MSNs, 
such as embedding functional materials in the mesoporous channels, and functionalizing 
the surface of the MSNs [74]. Because they cannot perform the targeted drug/protein 
delivery or track and evaluate the efficiency of the drug/protein release in diagnosis and 
therapy, it is necessary a combination of functional materials with the mesoporous 
channels, as a smart strategy to resolve these limitations, creating therefore luminescent 
MSNs. Luminescent labeling is a real-time, simple, and effective way to monitor the route of 
drug/protein delivery nanocarriers in a living system. Drug/protein delivery systems with 
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luminescent labels, such as QDs, can easily evaluate the efficiency of the drug/protein 
release and disease therapy, and also reduce the interference of the environment [31,75,76]. 
 
1.5. Characterization of nanoparticles 
In this report was performed a combination of several techniques used to provide 
a detailed and precise structural information of the nanoparticles. 
The standard characterization of MSNs included the use of electron microscopies 
(transmission electron microscopy, TEM, and scanning electron microscopy, SEM), X-ray 
powder diffraction (XRD/XRPD) and dynamic light scattering (DLS). The particle 
morphology was usually studied by SEM, while the ordered arrangement of the pores was 
detected by TEM. XRD was used to determine the ordered structure of the nanoparticles. 
1.5.1. Electron microscopy 
Electron microscopy is the best technique to study the size, shape and structure of 
nanoparticles. The electron microscope operates on the same basic principles as the light 
microscope however uses electrons instead of light, and because electrons have a much 
lower wavelength compared to photons, makes it possible to get a better resolution than 
with a light microscope [77].  
The more commonly used are TEM and SEM [77]. 
1.5.1.1. Transmission electron microscopy (TEM) 
Transmission electron microscopy is a microscopy technique in which a beam of 
electrons is transmitted through a specimen to form an image. TEM is composed by several 
elements, such as a vacuum system, where the electrons travel, an electron emission source 
to generate the electron stream, a series of electromagnetic lenses, as well as electrostatic 
plates [77-79]. 
A beam of electrons is generated by an electron gun and transmitted through the 
sample, interacting with the specimen as it passes through, creating an image from its 
interaction. Then the image is amplified and focused onto an imaging devise to be detected 
by a sensor, such as a charge-coupled device (CCD) camera. From these images, it is possible 
to obtain information about size and morphology, and also the distribution of the particles 
[77-79], Figure 1.4. 
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Figure 1.4 – Diagram outlining the internal components of a basic TEM system [80]. 
 
1.5.1.2. Scanning electron microscopy (SEM)  
In scanning electron microscopy, an image of the specimen topography is formed 
when its surface is scanned with a focused beam of electrons [77-79].  
Similar to TEM, a high voltage electron beam is created by an electron gun and 
focused to the sample by electrostatic and electromagnetic lenses. The primary electrons of 
the electron beam enter the sample and refract around one or several atomic nuclei, exciting 
the sample by nearly unchanged energy called backscattered electrons. When the beam 
scans a small area of the specimen surface, scattered secondary electrons are collected and 
an image of the specimen tomography is formed. Moreover, since the heavier nuclei refract 
more electrons, this method can be performed to determine the atomic composition of a 
sample [77-79], Figure 1.5. 
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Figure 1.5 – Scanning electron microscope (Hitachi’s SU6600 model) and schematic representation 
of the constituents’ parts [81,82]. 
 
1.5.2. X-ray powder diffraction (XRD/XRPD) 
X-ray powder diffraction is an analytical technique used for phase identification of 
a crystalline material by their diffraction pattern and it can provide information about unit 
cell dimensions [83].  
In this technique, electrons are accelerated by an electrostatic potential in order to 
gain the desired energy to hit a target and generate the X-rays. These X-rays are collimated 
and directed onto the powder sample. Then a detector detects the X-ray signal to be 
processed, Figure 1.6 [83]. 
When the X-ray beam hits the sample and is diffracted, it is possible to measure 
the distance between the adjacent planes of the atoms (d-spacings) that constitute the 
sample by applying Bragg's Law:  
(nλ=2d sin θ)                                              (Equation 1.1) 
where n is the order of the diffracted beam, λ is the wavelength of the incident X-ray beam, 
d is the d-spacings, and θ is the diffraction angle of the incident X-ray beam. This law relates 
the wavelength of electromagnetic radiation with the diffraction angle and the lattice 
spacing in a crystalline sample. The characteristic set of d-spacings generated in the X-ray 
scan provides a unique "fingerprint" of the material present in the sample that when 
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properly interpreted, by comparison with standard reference patterns and measurements, 
allows the identification of the material [83]. 
 
Figure 1.6 – Schematic representation of the XRD constituents’ parts [84]. 
 
1.5.3. Dynamic Light Scattering (DLS) 
Dynamic light scattering is used to determine the hydrodynamic size of a 
nanoparticle. It measures the Brownian motion of a particle at a certain speed, which is 




                                                (Equation 1.2) 
where k is the Boltzmann constant, η is the solvent viscosity, T is the absolute temperature, 
Dt is the diffusion coefficient and DH is the hydrodynamic diameter of the particle [85,86]. 
In the DLS instrument, Figure 1.7, when a sample is illuminated by a light source, 
such as laser, it scatters light in all directions. According to the Stokes-Einstein equation, 
Brownian motion of the particles is slower for bigger particles than for smaller particles, 
which leads to slower fluctuation of intensity-speckle change for bigger particles. In the case 
of a sample consisting of particles in two size classes equal in number, the bigger particles 
scatter more light resulting in a larger peak area by intensity. The size distribution of 
particles can also be determined by volume and by number. However, this data is normally 
generated from the raw data of the intensity [85,86]. 
 
Figure 1.7 – Dynamic light scattering instrument (Horiba SZ-100 Zetasizer Nano-Instrument model) 
[87]. 
12 
1.5.4. Spectroscopic Techniques  
In spectroscopic characterization, the techniques can be categorized into two 
groups: 
- Vibrational spectroscopy (Fourier transformed infrared spectroscopy); 
- Absorption and emission spectroscopy (absorption, photoluminescence). 
1.5.4.1. Fourier Transformed Infrared spectroscopy (FT-IR) 
This technique involves the interactions of photons with species in a sample which 
results in energy transfer to or from the sample, via vibrational excitation or de-excitation. 
Normally it is used to identify the type of bond between two or more atoms and 
consequently identify functional groups. In the FT-IR spectrometer, Figure 1.8, the infrared 
wavelengths range from 10 cm-1 to 14000 cm-1, however in this report it has been mainly 
used in the middle infrared region that correspond to wavelengths between 400 cm-1 to 
4000 cm-1, and it is where the main vibrational models appear [88]. 
 
Figure 1.8 – FT-IR spectrometer (PerkinElmer Spectrum Two spectrometer model) [89]. 
 
1.5.4.2. Absorption spectroscopy 
Absorption spectroscopy is an analytical technique, also called ultraviolet-visible 
(UV-Vis) spectrophotometry, based on the measurement of an amount of light absorbed by 
a sample at a given wavelength. The wavelength region is generally from 190 nm to               
1000 nm, and the absorbing medium is at room temperature. However, in some cases, such 
as enzyme assays, it may be advantageous or necessary to perform measurements at 
temperatures above or below room temperature [90]. 
In UV-Vis spectrophotometry, the major energy levels are determined primarily by 
the possible spatial distributions of the electrons, and are called electronic energy levels. As 
for the lower extent, they are referred to as vibrational energy levels, which arise from 
various modes of molecule vibration (e.g. the stretching and bending of various covalent 
bonds). As a result, absorbance measurements allow the determination of a substance 
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concentration, the kinetic assay of certain chemical reactions and the identification of 
materials [90]. The UV-Vis spectrophotometer applied in this report is presented in       
Figure 1.9. 
 
Figure 1.9 – UV-Vis spectrophotometer (JASCO V-630 model) [91]. 
 
1.5.4.3. Photoluminescence 
Photoluminescence refers to the emission of light from a material after absorption 
of photons (electromagnetic radiation). This emitted luminescence is originated from photo 
excitation onto a sample, then collected by lens and passed through an optical spectrometer 
onto a photodetector [90]. 
This technique, provides information about the luminescence capabilities, 
structural and chemical changes, and emission lifetimes of different samples [90]. These 
measurements are carried out using a fluorescence spectrofluorometer, Figure 1.10. 
 






1.6. Aim of dissertation  
As stated above, inorganic QDs have excellent optical properties; although, due to 
the use of heavy metal elements, they also are highly toxic and non-biodegradable. 
Therefore, Si QDs emerged as a new promising alternative to the toxic heavy-metal CdTe 
QDs, since they exhibit proper properties such as low toxicity and favorable 
biocompatibility and biodegradability. On the other hand, they are still chemically unstable, 
and as a result, they need to be incorporated into MSNs to provide better stability. However, 
MSNs have a drawback, which is low solubility and high PDI for in vitro and in vivo 
applications. 
Considering all these aspects, the aim of this master dissertation is to synthesize 
and characterize MSNs doped with QDs (silicon and cadmium telluride) and functionalized 
with a PEG derivative to improve the water solubility, and their further application as 
protein loading/extraction system, Scheme 1.3. 
 
Scheme 1.3 – Synthetic procedure of luminescent MSNs functionalized with PEG-Silane and their 
application as protein loading/extraction system. 
 
In Chapters 2 and 3 are summarized the synthesis and results concerning the 
formulation of the MSNs with CdTe QDs as a first approach (Chapter 2) and with Si QDs as 
the final approach and its optimization. 
Chapter 4 summarized the synthesis and results of PEG-derivatives (PEG1 – 
PEG(3000)-Silane, PEG2 – TsO-PEG(6000)-Silane, PEG3 – TsO-PEG(8000)-Silane), which 
were functionalized in the surface of the luminescent MSNs, Figure 1.11. 


















Figure 1.11 – PEG-derivatives discussed in Chapter 4. 
 















SYNTHESIS OF CdTe QDs COATED WITH 




Herein we will focus on the synthesis and characterization of CdTe QDs coated 
with MSNs and their further application as protein loading/extraction systems. CdTe QDs 
with green and orange emission were synthetized in aqueous solutions, and further mixed 
with CTAB and TEOS, resulting in the luminescent mesoporous silica nanoparticles. To 
increase the solubility of these systems in water, PEG1 was functionalized on their surface. 
KEYWORDS: Cadmium Telluride Quantum Dots, Mesoporous silica nanoparticles,              
PEG-Silane, Proteins. 
 
2.1.   EXPERIMENTAL SECTION 
2.1.1. Reagents and Chemicals: 
Thioglycolic acid (TGA, C2H4O2S, ≥99%), cadmium acetate dihydrate 
(Cd(CH3COO)2·2H2O, 99.5%), tetraethyl orthosilicate (TEOS, SiC8H20O4, 98%), 
cetyltrimethylammonium bromide (CTAB, C19H42BrN, ≥98%), bovine serum albumin (BSA), 
lysozyme (LYS), carbonic anhydrase (CA), ovalbumin (OVA), hemoglobin (Hb), myoglobin 
(Myb), cytochrome c (CYT) and phosphate buffered saline (PBS) were purchased from 
Sigma-Aldrich. Sodium borohydride (NaBH4, 99%) and ethylene glycol (C2H6O2, ≥99.5%) 
were produced by Fluka. Sodium tellurite (Na2TeO3, 99.5%) and ammonium nitrate 
(NH4NO3, 99.9%) were purchased from Alfa Aesar. Sodium hydroxide (NaOH) was produced 
by Panreac. Methanol (MeOH) was produced by Carlo Erba Reagents. All the reagents and 














2.1.2.1. Synthesis of CdTe QDs 
Cd(CH3COO)2·2H2O (53 mg, 0.2 mmol) was dissolved into 50 mL of bi-distilled 
water in a stand-up flask (solution A). Then 18 μL TGA was added and the pH was adjusted 
to 10, adding dropwise a solution of 1 M NaOH (by adding TGA the solution becomes cloudy 
and then the NaOH must be added until it is transparent). After that, 8.86 mg (0.04 mmol) 
of Na2TeO3 which was dissolved in 50 mL bi-distilled water (solution B) was added into the 
previous solution (solution A). Then 80 mg of NaBH4 was added to the final mixture and 
stirred at room temperature for 5 min. After this, the reaction mixture was divided in half 
and transferred into two twin-neck round-bottom flask which were attached to a condenser 
and refluxed at ~200°C under open-air conditions. The reaction time was controlled under 
UV light, giving green CdTe QDs at approximately 10 min and orange CdTe QDs at 
approximately 15 min [11]. 
2.1.2.2. Synthesis of CdTe QDs coated with MSNs (CdTeQDs@mSiO2) 
To the previous crude solution (2.1.2.1.) of CdTe QDs, was added 0.10 g of CTAB 
which was dissolved in 10 mL of bi-distilled water. This mixture was stirred for 30 min at 
50°C. By this order, bi-distilled water (30 mL), ethylene glycol (10 mL) and NaOH 1M        
(165 µL) was added to the above mixture and stirred for further 30 min at 70°C. Then,       
0.75 mL of TEOS was added dropwise to the mixture and left for 3 h at 70°C under stirring. 
The final product was washed three times with a solution of bi-distilled water and methanol. 
For template removal, a solution of 60 mg of NH4NO3 in 20 mL of methanol was added to 
the previous washed product and transferred to a round-bottom flask which was stirred for 
30 min at 60°C. The last three steps were repeated twice. 
2.1.2.3. Functionalization of green CdTeQDs@mSiO2 with PEG1 
(CdTeQDs@mSiO2@PEG1) 
A total of 200 mg of PEG1 was dissolved in 6.5 mL of bi-distilled water. Then, this 
solution was added to the green CdTeQDs@mSiO2 suspension with template (50 mg in        
6.5 mL of bi-distilled water), followed by 3 h of reflux at 100°C. The mixture was then stirred 
overnight at room temperature. The functionalized mesoporous nanoparticles were 
isolated by centrifugation (4000 rpm, 10 min), washed three times with bi-distilled water 
and twice with ethanol, and dried. The template was removed by the same procedure as 
mentioned in 2.1.2.2. After that, the final product was washed one time with bi-distilled 
water and twice with methanol, and dried [93]. 
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2.1.3. Protein encapsulation studies 
Protein stock solutions (0.5 mg/mL) of BSA, LYS, CA, OVA, Hb, Myb and CYT were 
prepared in phosphate buffer (0.01 M, pH 7.4). A suspension of luminescent MSNs                      
(2 mg/mL) in 1 mL of PBS was sonicated for 10 min. After that 0.5 mL of proteins were 
mixed with 0.5 mL of luminescent MSNs. The final suspensions were stirred for 30 min. The 
samples were centrifuged and the supernatant quantified by absorption using the Bradford 
assay in a CLARIOstar® High Performance Monochromator Multimode Microplate Reader 
(BMG LABTECH). The encapsulation efficiency (EE) and the loading capacity were 
determined by the following equations (tprotein: the total amount of protein/molecule; fprotein: 
the amount of free protein/molecule) [72]: 
𝐸𝐸 (%) =  
𝑡𝑝𝑟𝑜𝑡𝑒𝑖𝑛− 𝑓𝑝𝑟𝑜𝑡𝑒𝑖𝑛
𝑡𝑝𝑟𝑜𝑡𝑒𝑖𝑛
× 100%                          (Equation 2.1) 
𝑙𝑜𝑎𝑑𝑖𝑛𝑔 𝑐𝑎𝑝𝑎𝑐𝑖𝑡𝑦 (𝑚𝑔/𝑔) =  
𝑡𝑝𝑟𝑜𝑡𝑒𝑖𝑛  (𝑚𝑔)− 𝑓𝑝𝑟𝑜𝑡𝑒𝑖𝑛 (𝑚𝑔)
𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑛𝑎𝑛𝑜𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠
        (Equation 2.2) 
This study was performed for green CdTeQDs@mSiO2 and green 




The UV-Vis absorption spectra were acquired on a Jasco V-630 spectrophotometer. 
The fluorescence measurements were recorded using a FluoroMax4 spectrometer (Horiba 
Yvon Jobin) at room temperature. The fluorescence quantum yield (ΦF) of the CdTe QDs was 
estimated by comparison with acridine yellow in ethanol (ΦF = 0.47)[94] for the green QDs, 
and with rhodamine B in ethanol (ΦF = 0.70)[95] for the orange QDs. DLS to evaluate the 
particle size and zeta potential was carried out on a SZ-100 Zetasizer Nano-Instrument 
(Horiba). Morphology and size distribution were examined by SEM and TEM. SEM was 
performed in a SEM-FIB – Zeiss Auriga CrossBeam, workstation at Laboratory of 
Nanofabrication, CENIMAT, and TEM images was obtained in a JEOL JEM 2010F operating 
at 200 kV, and collected using a multi-scan camera and a Digital Micrograph software from 
Gatan. The XRD patterns were collected on a Rigaku, model MiniFlex II, diffractometer with 
a Cu Kα (λ = 1.5418 Å) radiation source (30 kV, 15 mA). Measurements were step-scanned 
in 0.02° 2θ steps in the 1-12° range, with a scan speed of 0.5°/min. Infrared spectra were 
recorded on a PerkinElmer BX or PerkinElmer Spectrum Two spectrometer.  
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2.2.  RESULTS AND DISCUSSION 
CdTe QDs were synthesized following the method reported by Wu and co-workers 
[11]. Briefly, CdTe QDs were obtained in one-pot method, in water and open-air conditions, 
using TGA as a ligand, without protection of nitrogen gas, and using Na2TeO3 as a stable Te 
source and NaBH4 as reducing agent. The CdTe QDs were then further coated with a 
monolayer of MSNs and functionalized with the polymer PEG1 in order to increase water 
solubility. 
 
2.2.1. CdTe QDs 
In Figure 2.1 is represented the absorption (Figure 2.1 – A) and fluorescence 
emission (Figure 2.1 – B) spectra of the green and orange CdTe QDs in aqueous solution, 
which were taken at different refluxing times from the reaction mixture. Additional analysis 
concerning the size, PDI, zeta potential and ΦF values of green and orange CdTe QDs are also 





By prolonging the refluxing time, is shown that the absorption spectra of the CdTe 
QDs as well as the fluorescence emission spectra shifted to longer wavelengths with the 
increase of the particle size as a consequence of the quantum confinement. This behavior 
was possible to confirm by evaluating the particle size, zeta potential through DLS (Figure 
























































CdTe QDs Size (nm) / PDI Zeta Potential (mV) ΦF (%)
Green 4.56 / 0.38 -16.47 31.46
Orange 9.48 / 0.66 -32.43 11.54
Figure 2.1 – (A) Absorption spectra of green CdTe QDs and orange CdTe QDs; (B) Fluorescence 
emission spectra of green CdTe QDs (λexc = 450 nm) and orange CdTe QDs (λexc = 500 nm) and images 
of the QDs under UV irradiation (λexc = 365 nm). (C) Size, PDI, zeta potential and ΦF values of green 
and orange CdTe QDs. 
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increasing the reaction time. 
After 10 min and 15 min of reflux, a maximum absorption was obtained at 489 nm 
and 553 nm, and emission at 528 nm and 586 nm corresponding to the green and orange 
CdTe QDs, respectively. 
As mentioned above, the size and zeta potential of the synthesized QDs were 
measured by DLS. Green QDs reached a size of ca. 4.6 nm and a zeta potential of ca. −16 mV, 
whereas for the orange QDs a size of ca. 9.5 nm and a zeta potential of ca. −32 mV was 
obtained. As expected, there is an increase in the size of the QDs, from green to orange QDs, 
and it was also observed that as the size increased the stability also increased, since the 
obtained values were shown to be negative with a value higher than −30 mV. Moreover, 
CdTe QDs presented ΦF values of 31.46% and 11.54% for the green and orange QDs, 
respectively. The values herein obtained are in agreement to the ones obtained in literature 
in the same conditions (pH = 10.0, 528 nm (ΦF = 30%) and 586 nm (ΦF = 15%)) [11]. 
To overcome the issue of instability, the crude CdTe QDs were coated with a layer 
of MSNs. 
 
2.2.2. CdTe QDs coated with MSNs (CdTeQDs@mSiO2) and functionalization 
of green CdTeQDs@mSiO2 with PEG1 
This synthesis consisted in the creation of a protective layer around the CdTe QDs 
to prevent their oxidation and degradation. Also, this layer allows the functionalization of 
other molecules on its surface, making them useful for biological applications, such as drug 
delivery systems or protein loading/extraction [34].  
As described in the experimental part (section 2.1.2.2.), in the synthesis of the 
MSNs, the cationic surfactant CTAB was used as a structural agent (template), TEOS as the 
silica source, ethylene glycol as the micelles stabilizer and sodium hydroxide as the 
morphological catalyst. Due to their poor solubility, the MSNs doped with CdTe QDs were 
characterized by solid-state emission spectroscopy to understand the effect of chemical 




Figure 2.2 – (A) Solid-state fluorescence emission spectra of (A) green (λexc = 450 nm) and orange 
(λexc = 500 nm) CdTeQDs@mSiO2, and (D) green CdTeQDs@mSiO2@PEG1 (λexc = 450 nm). Inset A, D: 
(G, O, P) Naked eye and (G*, O*, P*) under UV irradiation (exc = 365 nm) of green CdTeQDs@mSiO2, 
orange CdTeQDs@mSiO2 and green CdTeQDs@mSiO2@PEG1, respectively photographs. (B-C) Naked 
eye and (B*-C*) under UV irradiation (exc = 365 nm) of green and orange CdTeQDs@mSiO2 
photographs. (E) Naked eye and (E*) under UV irradiation (exc = 365 nm) of green 
CdTeQDs@mSiO2@PEG1 photographs. (F) Infrared spectra of green and orange CdTeQDs@mSiO2 
and PEGylated green CdTeQDs@mSiO2. (G) Size, PDI and zeta potential values of green and orange 
CdTeQDs@mSiO2 and green CdTeQDs@mSiO2 functionalized with PEG1. All these measurements 
were performed without template. 
   
The solid-state emission spectra show a maximum of emission at 546 nm and       
584 nm corresponding to the green and orange CdTeQDs@mSiO2, respectively. It was 
possible to observe a slight shift in the maximum emission wavelength from CdTe QDs to 
CdTeQDs@mSiO2, which can be explained by the change in ground-state and excited-state 
energies along with the change in the surrounding environments [42]. 
The images of CdTeQDs@mSiO2 at naked eye (Figure 2.2 – B-C) and under an 
ultraviolet lamp (λexc = 365 nm, Figure 2.2 – B*-C*) are also presented, and they showed that 
no changes were detected in the color of the CdTeQDs@mSiO2 compared with the CdTe QDs 
after the functionalization of the QDs with the MSNs. 
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Size (nm) / PDI Zeta Potential (mV)
Green CdTeQDs@mSiO2 1012 / 0.48 -13.43
Orange CdTeQDs@mSiO2 1003 / 0.63 -14.17








QDs, however consequently was created a system with low water solubility for biological 
applications. Therefore, the functionalization of a polymer onto the mesoporous silica 
surface was needed.  
This synthesis consisted of the increase of water solubility of the CdTeQDs@mSiO2, 
by functionalizing the surface with the polymer PEG1. After removing the surfactant of the 
nanoparticles, the powder obtained was characterized by solid-state emission spectra, 
Figure 2.2 – D. It was possible to observe a maximum of emission at 571 nm corresponding 
to the green CdTeQDs@mSiO2@PEG1 obtained. Any significant reduction in the 
fluorescence is observed. However a red shift of 25 nm (from 546 nm to 571 nm) is 
visualized in the maximum of emission band compared with green CdTeQDs@mSiO2. As a 
result there was a change in color of the powder under UV irradiation from green to yellow, 
as can be seen in Figure 2.2 – E*. 
Infrared spectra of the green CdTeQDs@mSiO2 and CdTeQDs@mSiO2@PEG1 
nanoparticles (Figure 2.2 – F) was performed to confirm the chemical binding of the 
products. The typical peaks at 3387 cm-1, 1072 cm-1, 965 cm-1 corresponding to the 
vibrations O-H, Si-O-Si and Si-O-H are detected in CdTeQDs@mSiO2 nanoparticles, 
confirming the pure nature of the mesoporous nanoparticles and the presence of silanol 
groups at its surface. The PEGylated nanoparticles show the characteristic peaks at            
2980 cm-1 corresponded to C-H of methyl and methylene groups of the polymer chain. 
Additionally, peaks at 1736 cm-1, 1366 cm-1 and 1206 cm-1 are characteristic of C=O, NH, and 
CH of the polymer backbone, respectively. 
All these nanoparticles were also characterized by DLS (Figure 2.2 – G). DLS 
measurements were carried out in water, and the values of size suggest that by coating the 
CdTe QDs with mesoporous silica we were able to observe an increase in size compared 
with CdTe QDs. Moreover, it shows larger particle sizes for the sample containing the 
polymer PEG1 in comparison to the unfunctionalized green CdTeQDs@mSiO2 
nanoparticles. Despite the increase in the hydrodynamic diameter, the introduction of a PEG 
polymer, increases the stability of these nanoparticles leading to a more negative and stable 
zeta potential (changes from ca. −13 mV to −34 mV). In the same way, the aggregation state 
decreases as can be seen in the decrease of the PDI. In contrast, the unfunctionalized 
nanoparticles tend to aggregate in water, more in orange nanoparticles than in green 
nanoparticles, confirmed by a higher PDI. 
The morphology of the nanoparticles was confirmed by TEM and SEM images of 
green CdTeQDs@mSiO2@PEG1 (Figure 2.3). TEM and SEM images proved the spherical 
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shape of the nanoparticles, as well as their pore in Figure 2.3 – C, represented by the white 
dots. Through TEM and SEM images, was noticed that green CdTeQDs@mSiO2@PEG1 
nanoparticles have a size around 89 ± 7 nm. In general, the particle sizes obtained by DLS 
measurements are larger than those obtained from TEM and SEM measurements, since (i) 
the hydrodynamic diameter is measured and (ii) some degree of weak agglomeration can 
also increase the apparent particle size distribution [68]. 
 
Figure 2.3 – (A-C) TEM images of green CdTeQDs@mSiO2@PEG1. (D-E) SEM image of green 
CdTeQDs@mSiO2@PEG1. The inset image shows the corresponding size distribution. 
 
Powder XRD experiment also was performed to determine the specific structure 
of the obtained product. XRD pattern of the green and orange CdTe QDs MSNs without 






































































Figure 2.4 – Powder X-ray diffraction pattern of green and orange CdTeQDs@mSiO2 without 
template. 
 
In both cases, the XRD analysis shows the three-typical low-angle reflections of a 
hexagonal array, which can be numbered as (100), (110) and (200) Bragg peaks [28]. These 
results suggest well-ordered mesoporous nanoparticles. The broad peak located in the 
range of 15-35° indicate the presence of amorphous silicon dioxide. The maximum peak at 
24.5° corresponds to the plane (111) of the cubic zinc blende structure of CdTe crystal [42]. 
 
2.2.3. Encapsulation studies on green CdTeQDs@mSiO2 and PEGylated green 
CdTeQDs@mSiO2 
Encapsulation studies of the green CdTeQDs@mSiO2 and PEGylated green 
CdTeQDs@mSiO2 in physiological pH (PBS, pH = 7.4) with single proteins exhibiting 
different sizes and pI, such as BSA, LYS, CYT, Myb, Hb, CA and OVA were accomplished. These 
proteins were selected due to the wide variety of physical properties they collectively 
presented (Table 2.1 and Table A.1 - Appendix).  
The proteins were incubated with the nanoparticles in PBS, with a weight ratio of 
1:4 (protein:MSNs) for incubation times of 30 min. EE and the amount adsorbed were 
determined accordingly with section 2.1.3. in the experimental part, and the obtained 





Table 2.1 – List of encapsulated proteins and their properties. aGeometric dimensions given by 
published literature [96,97]. bThe residue count of these proteins come from the Protein Data Bank. 
PDB codes: BSA, 3V03; LYS, 1DPX; CYT, 1HRC; Myb, 1WLA; Hb, 1A3N; CA, 1V9E; OVA, 1OVA.  
 
 
Figure 2.5 – Encapsulation efficiency and corresponding loading capacity of several proteins in 
green CdTeQDs@mSiO2 and PEGylated green CdTeQDs@mSiO2, weight ratio of 1:4 (protein:MSNs) 
in PBS pH = 7.4.  
 
Zeta potential analysis (Figure 2.2 – G) revealed a negative surface charge for green 
CdTeQDs@mSiO2 and PEGylated green CdTeQDs@mSiO2 (−13.43 mV and −34.27 mV, 
respectively). Consequently, it should be expected an effect of the charge in the extent of the 
protein encapsulation, being a more efficient encapsulation for proteins with a positive 
surface charge, such as LYS and CYT. However, no significant changes were observed, as a 
matter of fact, the encapsulation with the negative/neutral charged proteins Hb, CA, OVA 
was more efficient, with EE around 70% and a loading capacity of ca. 150-200 mg/g, 
indicating that electrostatic interactions were not the main driving force for protein 
encapsulation. Moreover, the addition of PEG1 resulted in a slight decrease in the affinity of 
the nanoparticles to the proteins.  
 





Bovine Serum Albumin (BSA) 69293 5 x 5 x 9 4.9 6.6 22.7
Lysozyme (LYS) 16239 3 x 3 x 4.5 10–10.5 4.8 28.6
Cytochrome C (CYT) 11833 2.6 x 3.2 x 3.3 11.35 2.9 23.8
Myoglobin (Myb) 17083 ca. 17.6 6.8-7.2 5.2 16.2
Hemoglobin (Hb) 15998 5.3 x 5.4 x 6.5 6.8 4.8 13.6
Carbonic Anhydrase (CA) 28822 3.9 x 4.2 x 5.5 5.9 5.7 16.1











BSA LYS CYT Myb Hb CA OVA
GreenQDs@mSiO
2
 - EE (%) 30 min.
Green@PEG1 - EE (%) 30 min.
GreenQDs@mSiO
2
 - Loading capacity (mg/g) 30 min.
























In summary, fluorescent CdTe QDs coated with MSNs have been successfully 
obtained and good dispersions in water were obtained through the introduction of PEG 
derivatives. Different techniques were applied to characterize CdTeQDs@mSiO2 and 
PEGylated nanoparticles. Experiments prove that QDs coated with MSNs can induce a great 
improvement on the photo-stability of the QDs. Moreover, the functionalization of a 
polymer PEG1 onto the mesoporous silica surface also improved the problem of poor water 
solubility caused by the introduction of the protective layer of MSNs. The morphology of 
these nanoparticles with a size around 89 ± 7 nm for PEGylated nanoparticles, was also 
confirmed by TEM and SEM images, which proved to be of spherical shape. In addition, 
green CdTeQDs@mSiO2 and CdTeQDs@mSiO2@PEG1 have demonstrated a large affinity for 
several negative/neutral charged proteins, such as Hb, CA and OVA. Moreover, the addition 
of PEG1 resulted in a slight decrease in the affinity of the nanoparticles to the proteins. Due 













SYNTHESIS OF Si  QDs COATED WITH 




Herein we will focus on the synthesis and characterization of Si QDs coated with 
MSNs and their further application as protein loading/extraction systems. Si QDs were 
synthesized in aqueous solutions, optimized and coated with MSNs, resulting in the 
luminescent mesoporous silica nanoparticles. To increase the solubility of these systems in 
water, PEG-Silane derivatives were functionalized on their surface.  
KEYWORDS: Silicon Quantum Dots, Mesoporous silica nanoparticles, PEG-Silane, Proteins. 
 
3.1. EXPERIMENTAL SECTION 
3.1.1. Reagents and Chemicals: 
(3-Aminopropyl)trimethoxysilane (APTMS, H2N(CH2)3Si(OCH3)3, 97%),                      
(3-aminopropyl)triethoxysilane (APTES, H2N(CH2)3Si(OC2H5)3, 99%), (+)-sodium                      
L-ascorbate (SA, C6H7NaO6, ≥98%), tetraethyl orthosilicate (TEOS, SiC8H20O4, 98%), 
tetramethyl orthosilicate (TMOS, SiC4H12O4, 98%), ammonia (NH3, ≥99.9%), 
cetyltrimethylammonium bromide (CTAB, C19H42BrN, ≥98%), %), bovine serum albumin 
(BSA), lysozyme (LYS), carbonic anhydrase (CA), ovalbumin (OVA), hemoglobin (Hb), 
myoglobin (Myb), cytochrome c (CYT) and phosphate buffered saline (PBS) were purchased 
from Sigma-Aldrich. Ascorbic Acid (AA, C6H8O6, 99%) and sodium hydroxide (NaOH, ≥98%) 
were produced by Panreac. Ammonium nitrate (NH4NO3, 99.9%) was purchased from Alfa 
Aesar. Ethylene glycol (C2H6O2, ≥99.5%) and (3-isocyanatopropyl)triethoxysilane (IPTES, 
(C2H5O)3Si(CH2)3NCO, 95%) were produced by Fluka. Methanol (MeOH) and ethanol (EtOH) 
were produced by Carlo Erba Reagents. All the reagents and solvents were of analytical 














3.1.2.1. Assay A (proof-of-concept) 
3.1.2.1.1. Synthesis of Si QDs (Si QDs I and II) 
The Si QDs were prepared by adding 1 mL of APTMS in the synthesis I and APTES 
in the synthesis II to 4 mL of bi-distilled water while stirring. Then, 1.25 mL of 0.1 M SA was 
added to the above mixture and stirred for 30 min at room temperature [25].  
3.1.2.1.2. Synthesis of Si QDs coated with MSNs (SiQDs@mSiO2 I and II) 
To the previous crude solution (3.1.2.1.1.) of Si QDs was added 10 mL of an 
aqueous solution of 0.1 M CTAB. This mixture was stirred for 30 min at room temperature. 
500 µL of ammonia was added to the mixture and stirred for further 30 min. Then, 500 µL 
of TEOS was added dropwise to the mixture and left for 2 h at 80°C under stirring. The final 
product was washed with ethanol and filtered. For template removal, a solution of 60 mg of 
NH4NO3 in 20 mL of methanol was added to the previous washed product and transferred 
to a round-bottom flask which was stirred for 30 min at 60°C. The last three steps were 
repeated twice. The reaction mixture was washed three times with bi-distilled water and 
methanol, and dried. 
3.1.2.1.3. Functionalization of SiQDs@mSiO2 with PEG1 
(SiQDs@mSiO2@PEG1 I and II) 
200 mg of PEG1 were previously dissolved in 6.5 mL of bi-distilled water. Then, 
this solution was added to the SiQDs@mSiO2 (with template) suspension I and II (50 mg in 
6.5 mL of bi-distilled water), followed by 3 h of reflux at 100°C. The functionalized 
mesoporous nanoparticles were isolated by centrifugation, washed three times with              
bi-distilled water and twice with ethanol, and dried. For template removal it was followed 
the same procedure reported in 3.1.2.1.2. [93].  
 
3.1.2.2. Si QDs Optimizations 
3.1.2.2.1. Varying the ratio of reducing agent and water 
The Si QDs were prepared by adding 1 mL of APTMS to different amounts of             
bi-distilled water and 0.1 M of SA and AA, accordingly with Table 3.1. Then the mixtures 
were stirred for 1 h at 40°C [26]. 
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Table 3.1 – Parameters used in the synthesis. 
 
Reducing agent - AA Reducing agent - SA 
APTMS (mL) H20 (mL) AA (mL) APTMS (mL) H20 (mL) SA (mL) 
E0) 1 5.25 - 1 5.25 - 
E1) 1 4 1.25 1 4 1.25 
E2) 1 3 2.25 1 3 2.25 
E3) 1 2 3.25 1 2 3.25 
E4) 1 1 4.25 1 1 4.25 
E5) 1 - 5.25 1 - 5.25 
3.1.2.2.2. Varying the concentration of the reducing agent 
The Si QDs were prepared by the same procedure reported in 3.1.2.2.1., which to 
1 mL of APTMS and 4 mL of bi-distilled water were added different concentrations of SA 
and AA (see Table 3.2). 
Table 3.2 – Parameters used in the synthesis. 
 
Reducing agent - AA Reducing agent - SA 
APTMS 
(mL) 
H20 (mL) AA (mL) 
APTMS 
(mL) 
H20 (mL) SA (mL) 
R1) 1 4 1.25 (0.05 M) 1 4 1.25 (0.05 M) 
R2) 1 4 1.25 (0.10 M) 1 4 1.25 (0.10 M) 
R3) 1 4 1.25 (0.15 M) 1 4 1.25 (0.15 M) 
R4) 1 4 1.25 (0.20 M) 1 4 1.25 (0.20 M) 
3.1.2.2.3. Varying the silane source and reducing agent volumes 
The Si QDs were prepared by adding 2 mL of APTMS to 4 mL of bi-distilled water 
while stirring. Then, 4 mL of 0.1 M SA were added to the above mixture and stirred for 2 h 
at 50°C. 
 
3.1.2.3. Assay B 
3.1.2.3.1. Synthesis of Si QDs functionalized with IPTES (SiQDs@Isoc) 
After optimization of the reaction described in 3.1.2.2., the procedure 3.1.2.2.2. R2) 
was selected, and the Si QDs were prepared following this procedure with AA. After 30 min 
under stirring, the temperature was removed and 2 mL of IPTES were added to the mixture 
and stirred for 2 h at room temperature (a white precipitate was form after the addition of 
IPTES. The mixture was centrifuged, washed 3 times with bi-distilled water and dried. 
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3.1.2.3.2. Synthesis of SiQDs@Isoc coated with MSNs (SiQDs@Isoc@mSiO2) 
3.1.2.3.2.1.  Via i (T1 and T2) 
To the previous SiQDs@Isoc (200 mg), 0.10 g of CTAB were added which was 
dissolved in 10 mL of bi-distilled water. This mixture was stirred for 30 min at 50°C. By this 
order, bi-distilled water (30 mL), ethylene glycol (10 mL) and NaOH 1 M (165 µL) were 
added to the mixture above and stirred for further 30 min at 70°C. Then, 0.75 mL of TEOS 
(T1) or TMOS (T2) were added dropwise to the mixture and left for 3 h at 70°C under 
stirring. The final product was washed three times with methanol. For the removal of the 
template it was followed the same procedure reported in 3.1.2.1.2. 
3.1.2.3.2.2.  Via ii (T3 and T4) 
To the previous SiQDs@Isoc (200 mg), 10 mL of an aqueous solution of 0.1 M CTAB 
was added. This mixture was stirred for 30 min at room temperature. 500 µL of ammonia 
were added to the mixture above and stirred for further 30 min at 50°C. Then, 500 µL of 
TEOS (T3) or TMOS (T4) were added dropwise to the mixture and left for 2 h at 80°C under 
stirring. The final product was centrifuged and washed 3 times with ethanol. For the 
removal of the template it was followed the same procedure reported in 3.1.2.1.2.  
3.1.2.3.3. Functionalization of SiQDs@Isoc@mSiO2 (T3) with PEG3 
(T3@PEG3) 
A total of 200 mg of PEG3 was dissolved in 13 mL of bi-distilled water. Then, this 
solution was added to the SiQDs@Isoc@mSiO2 (T3) suspension without template (50 mg in 
13 mL of bi-distilled water), followed by 3 h of reflux at 100°C. The functionalized 
mesoporous nanoparticles were isolated by centrifugation, washed five times with                   
bi-distilled water in eppendorf-tubes, and dried [93].  
 
3.1.2.4. Assay C 
3.1.2.4.1. Synthesis of Si QDs coated with MSNs (SiQDs@mSiO2) 
To the crude Si QDs solution in 3.1.2.2.3. was added 10 mL of an aqueous solution 
of 0.1 M CTAB. This mixture was stirred for 30 min at 50°C. 500 µL of ammonia were added 
to the mixture above and stirred for further 5-10 min. Then, 1 mL of TEOS was added 
dropwise to the mixture and left for 2 h at 70°C under stirring. After that, the mixture was 
stirred overnight at room temperature. The mixture was centrifuged, washed 3 times with 
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methanol and dried. This method was performed using 240/500/750/1000 µL of TEOS, 
however only by adding 1000 µL of TEOS the pellet was formed. For template removal it 
was followed the same procedure reported in 3.1.2.1.2. 
3.1.2.4.2. Functionalization of SiQDs@mSiO2 with TsO-PEG-Silane 
(SiQDs@mSiO2@PEG) 
 
3.1.2.4.2.1. Synthesis of SiQDs@mSiO2@PEG2 (C1)  
A total of 400 mg of PEG2 was dissolved in 13 mL of bi-distilled water. Then, this 
solution was added to the SiQDs@mSiO2 (with template) suspension (100 mg in 13 mL of 
bi-distilled water), followed by 3 h of reflux at 100°C. The functionalized mesoporous 
nanoparticles were isolated by centrifugation, washed two times with methanol and three 
times with bi-distilled water, and dried. For the removal of the template it was followed the 
same procedure reported in 3.1.2.1.2. [93]. 
3.1.2.4.2.2. Synthesis of SiQDs@mSiO2@PEG3 (C2) 
Same procedure performed in section 3.1.2.4.2.1., however applying 240 mg of 
PEG3 into 60 mg of SiQDs@mSiO2 suspension.  
 
3.1.2.5. Assay D 
3.1.2.5.1. Synthesis of Si QDs functionalized with IPTES (SiQDs@Isoc) 
To the crude Si QDs solution in 3.1.2.2.3., 2 mL of IPTES were added to the mixture 
and stirred for 2 h at room temperature. 
3.1.2.5.2. Synthesis of SiQDs@Isoc coated with MSNs 
(SiQDs@Isoc@mSiO2, D1) 
To the previous SiQDs@Isoc (250 mg), was performed the same procedure 
described in section 3.1.2.4.1., however by adding 240 µL of TEOS. 
3.1.2.5.3. Functionalization of SiQDs@Isoc@mSiO2 with PEG3 (D1@PEG3)  
Same procedure performed in section 3.1.2.4.2.1., however applying 400 mg of         
PEG3 into 100 mg of D1 suspension.  
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3.1.3. Protein encapsulation studies 
Protein stock solutions (0.5 mg/mL) of BSA, LYS, CA, OVA, Hb, Myb and CYT were 
prepared in phosphate buffer (0.01 M, pH 7.4). A suspension of blue luminescent MSNs          
(2 mg/mL) in 1 mL of PBS was sonicated for 10 min. After that 0.5 mL of proteins were 
mixed with 0.5 mL of blue luminescent MSNs. The final suspensions were stirred for 30 min. 
The samples were centrifuged and the supernatant quantified by absorption using the 
Bradford assay in a CLARIOstar® High Performance Monochromator Multimode Microplate 
Reader (BMG LABTECH). The encapsulation efficiency (EE) and the loading capacity were 
determined by the following equations (tprotein: the total amount of protein; fprotein: the 
amount of free protein) [72]: 
𝐸𝐸 (%) =  
𝑡𝑝𝑟𝑜𝑡𝑒𝑖𝑛− 𝑓𝑝𝑟𝑜𝑡𝑒𝑖𝑛
𝑡𝑝𝑟𝑜𝑡𝑒𝑖𝑛
× 100%                         (Equation 3.1) 
𝑙𝑜𝑎𝑑𝑖𝑛𝑔 𝑐𝑎𝑝𝑎𝑐𝑖𝑡𝑦 (𝑚𝑔/𝑔) =  
𝑡𝑝𝑟𝑜𝑡𝑒𝑖𝑛  (𝑚𝑔)− 𝑓𝑝𝑟𝑜𝑡𝑒𝑖𝑛 (𝑚𝑔)
𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑛𝑎𝑛𝑜𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠
         (Equation 3.2) 
This study was performed for T3 and T3@PEG3 (section 3.1.2.3.2.2. and 




The UV-Vis absorption spectra were acquired on a Jasco V-630 spectrophotometer. 
The fluorescence measurements were recorded using a FluoroMax4 spectrometer (Horiba 
Yvon Jobin) at room temperature. The fluorescence quantum yield (ΦF) of the Si QDs was 
estimated by comparison with fluorescein in ethanol (ΦF = 0.79) [98]. DLS to evaluate the 
particle size and zeta potential was carried out on a SZ-100 Zetasizer Nano-Instrument 
(Horiba). Morphology and size distribution were examined by SEM and TEM. SEM was 
performed in a SEM-FIB – Zeiss Auriga CrossBeam, workstation at Laboratory of 
Nanofabrication, CENIMAT and TEM images were obtained in a JEOL JEM 2010F operating 
at 200 kV, and collected using a multi-scan camera and a Digital Micrograph software from 
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3.2. RESULTS AND DISCUSSION 
Si QDs were synthesized following the method reported by Wang and co-workers 
[25], however with some modifications. Briefly, Si QDs were obtained in a one-step 
synthesis, in water and open-air conditions, being further coated with a monolayer of MSNs. 
A first assay (Assay A) was carried out as a proof-of-concept, and from this point, several 
modifications concerning the synthesis of Si QDs and their further coating with MSNs were 
optimized (Assays B-D). 
3.2.1. Assay A (proof-of-concept) 
Regarding Assay A, APTMS (I) and APTES (II) were used as silica source and SA as 
a reducing agent, as can be seen in the experimental section 3.1.2.1.1. After 30 min at room 
temperature, green fluorescent Si QDs were obtained (see Figure 3.1). Both Si QDs show in 
the absorption spectra (Figure 3.1 – A), two bands, one at 370 nm and another at ca. 520 nm 
characteristic of its red naked-eye color. As for the emission spectra, a band with a 
maximum at 510 nm and 501 nm, was obtained for the Si QDs I and II, respectively. 
These Si QDs were also characterized by DLS and ΦF (Figure 3.1 – C). Through DLS 
analysis both presented a similar size around 3.6-3.8 nm, and the ΦF values of QDs I and II 
were of ca. 13%, which was slightly lower than the one reported in the literature (21%) 
[25]. In the same way, the fluorescence emission bands were blue shifted regarding the    
530 nm presented in the literature [25]. The zeta potential showed to be negative with a 
value ca. –4 mV, revealing the instability of these quantum dots. To overcome such issue and 
increase the stability, the crude Si QDs were coated with a layer of MSNs. 
 
Figure 3.1 – Absorption (A) and fluorescence emission (B) spectra of Si QDs I and II (λexc = 370 nm) 
and images of the Si QDs at naked eye and under UV irradiation (λexc = 365 nm). (C) Size, PDI, zeta 









































Si QDs Size (nm) / PDI Zeta Potential (mV) ΦF (%)
I 3.56 / 0.73 -3.66 12.47
II 3.84 / 0.71 -3.67 13.25
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As can be seen in Figure 3.2, the addition of a layer of MSNs to the crude Si QDs, 
induces a blue shift in the emission bands of the Si QDs, from 500-510 nm to 467-468 nm. 
Moreover, the functionalization of PEG also promotes a blue shift in the emission bands to 
452-459 nm. Since the mesoporous nanoparticles were not very soluble in water, the 
obtained hydrodynamic sizes were not very precise, with values of ca. 660 nm for 
SiQDsI@mSiO2 and 3375 nm for SiQDsII@mSiO2. On the other hand, in all cases an inversion 
of the zeta potential was visualized, from ca. −4 mV to ca. 17-27 mV, confirming the surface 
coating and further PEG functionalization. Furthermore, the addition of PEG greatly 
increases the stability of the nanoparticles, obtaining the lowest PDI values of ca. 0.3 for 
SiQDs@mSiO2@PEG1 I and II. 
The infrared spectra (Figure 3.2 – E) show the characteristic peaks of the silica 
framework at 1046 cm-1 and 1049 cm-1, corresponding to the vibration Si-O-Si. Additionally, 
in the SiQDsII@mSiO2 a broad band at 3600-3100 cm-1 is associated with absorbed water 
and silanol groups at the mesoporous surface, and the vibration at ca. 1650 cm-1, indicates 
the bending modes of physisorbed water. The PEG silane functionalization was confirmed 
by the appearance of the peaks at 1516-1521 cm-1 and 1325 cm-1, corresponding to the 
vibration NH and CH of the polymer, respectively. 
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Figure 3.2 – (A) SiQDs@mSiO2 I and II, and (B) with PEG1 solid-state emission spectra                              
(λexc = 370 nm). (I-II) Naked-eye and (I*-II*) under UV irradiation (exc = 365 nm) photographs of (C) 
SiQDs@mSiO2 I and II, and (D) functionalized with PEG1. (E) Infrared spectrum. (F) Size and zeta 
potential values of SiQDs@mSiO2 I and II and PEGylated SiQDs@mSiO2 I and II (solvent: water). 
(without template) 
 
To confirm the morphology and size of the MSNs, the sample 
SiQDsII@mSiO2@PEG1 was analyzed by TEM, and the images are depicted in Figure 3.3. The 
SiQDsII@mSiO2@PEG1 are quite aggregated, however, they are spherical and with size 
around 30 nm. 
Overall, the spectral changes observed, DLS measurements, TEM and IR peaks, 
indicate that the syntheses were successfully carried out. Nevertheless some modifications 











































































Size (nm) / PDI Zeta Potential (mV)
SiQDsI@mSiO2 659.9 / 0.61 26.60
SiQDsI@mSiO2@PEG1 - / 0.31 16.70
SiQDsII@mSiO2 3375 / 0.41 18.00
SiQDsII@mSiO2@PEG1 1151 / 0.29 20.50
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Figure 3.3 – TEM images of SiQDsII@mSiO2@PEG1 (without template). 
 
3.2.2. Si QDs Optimizations 
Given the previous results, the first step was to optimize and improve the stability 
of the Si QDs. To accomplish that, several experiences were performed with APTMS, 
changing the reducing agent (AA or SA), temperature and reaction time, as follows: i) the 
ratio between the reducing agent and water (3.1.2.2.1., Experimental Section, ES), ii) the 
concentration of the reducing agent (3.1.2.2.2., ES), and finally iii) varying the volumes of 
the silane source and reducing agent, as well as the temperature and reaction time 
(3.1.2.2.3., ES). 
3.2.2.1. Varying the ratio of reducing agent and water 
Figure 3.4 shows the fluorescence emission spectra of Si QDs in aqueous solution 
with the AA and SA ratios reported in 3.1.2.2.1. ES, as well as their naked-eye and under a 
UV lamp (exc = 365 nm) colors. Additional analysis, concerning the variation of size, PDI, 
zeta potential and ΦF of Si QDs are presented in Figure 3.5. 
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Figure 3.4 – (A) Fluorescence emission spectra of Si QDs (λexc = 370 nm) while increasing the 
quantity of AA (above) and SA (below) reducing agents in water. (B) Naked eye and (C) under UV 












































Figure 3.5 – Values of size, PDI, zeta potential and ΦF of Si QDs at different amounts of reducing 
agent. 
Regarding the fluorescence emission spectra, no significant changes were 
observed when varying the ratio reducing agent: water. The same behavior was verified in 
the observed colors, as well as in the size, PDI and ΦF, with values around 3.5 nm, 0.45, and 
6%, respectively. Moreover, by increasing the reaction time (from 30 min to 1 h) and 
temperature (from room temperature to 40°C), in comparison with the previous synthesis 
in 3.1.2.1. ES, an improvement in the PDI from 0.7 to 0.45 was detected, yet with a decrease 
in the ΦF from 13% to 6%. On the other hand, besides the unchanged zeta potential for SA, 
an inversion in zeta potential from −0.7 mV to 3 mV was evidenced for high amounts of 
reducing agent. Overall, this change is not significant from the point of stability, since the 





1.25 mL 2.25 mL 3.25 mL 4.25 mL 5.25 mL
AA 3.27 3.45 3.50 3.64 3.57
















1.25 mL 2.25 mL 3.25 mL 4.25 mL 5.25 mL
AA 0.71 0.46 0.39 0.43 0.49













1.25 mL 2.25 mL 3.25 mL 4.25 mL 5.25 mL
AA -0.71 0.90 1.55 2.43 2.96






















1.25 mL 2.25 mL 3.25 mL 4.25 mL 5.25 mL
AA 5.85 5.57 5.87 6.21 5.81














3.2.2.2. Varying the concentration of the reducing agent 
In Figures 3.6 and 3.7 are represented the fluorescence emission spectra of Si QDs 
in aqueous solution, including their naked-eye and under a UV lamp (exc = 365 nm) colors, 
and the variation of size, PDI, zeta potential and ΦF, while increasing the concentration of 
reducing agent. 
 
Figure 3.6 – (A) Fluorescence emission spectra of Si QDs (λexc = 370 nm) while increasing the 
concentration of AA (above) and SA (below) reducing agents in water. (B) Naked eye and (C) under 












































Figure 3.7  – Values of size, PDI, zeta potential and ΦF Si QDs at different amounts of reducing agent. 
 
Based on Figure 3.7, the size of the quantum dots is not influenced by the 
concentration of the reducing agent, as well as the PDI, maintaining similar values for all 
experiments of ca. 0.6. As for the zeta potential, in case of AA it rises to higher positive 
values, but on the other hand, for SA maintains its negative values, being the most negative 
for 0.10 M of SA. The fluorescence emission spectra do not present significant alterations 
for the reducing agent AA and SA, which is also confirmed through the ΦF with values of ca. 
10% and 6% for AA and SA, respectively. 
To sum up, based on such results, the increasing amount of reducing agent does 
not favor the stability, nor the fluorescence signal intensity. Aiming more stable quantum 
dots, another experiment varying the silane and reducing agent volumes was performed. 
3.2.2.3. Varying the silane source and reducing agent volumes 
In Figure 3.8 it is represented the fluorescence emission spectra of Si QDs in 
aqueous solution, and their naked-eye and under a UV lamp (exc = 365 nm) colors. Plus, the 
values of size, PDI, zeta potential and ΦF of Si QDs are also presented. 
0.05 M 0.10 M 0.15 M 0.20 M
AA 3.06 3.31 3.39 3.31















0.05 M 0.10 M 0.15 M 0.20 M
AA 0.70 0.56 0.49 0.67
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AA -0.74 -0.93 -0.03 0.23



















0.05 M 0.10 M 0.15 M 0.20 M
AA 10.17 9.79 9.35 8.34












Figure 3.8 – (A) Fluorescence emission spectra of Si QDs (λexc = 370 nm). (B) Naked eye and (C) 
under UV irradiation (λexc = 365 nm) Si QDs photographs. (D) Size, PDI, zeta potential and ΦF values 
of Si QDs. 
 
For the same volume of water (4 mL), 2 mL of APTMS and 4 mL of SA were kept 
under stirring for 2 h at 50°C. The resulting quantum dots were of green emission with a 
maximum band centered at 509 nm. A more intense red color was noticed, and a 
hydrodynamic diameter of ca. 4 nm with a zeta potential of ca. −1.4 mV was obtained. 
Despite the improvement in the PDI from 0.4 to 0.19, the ΦF was around 6%, which is lower 
than the one synthesized in 3.1.2.1. ES. 
Based on the previous results, and in order to obtain more stable nanoparticles, 
the Si QDs produced in 3.1.2.2.2. R2) and in 3.1.2.2.3., in the experimental section were 
chosen to be firstly functionalized with IPTES and further coated with MSNs – Assay B and 
D. Additionally, the Si QDs 3.1.2.2.3. were functionalized with different thicknesses of MSNs 
– Assay C. 
 
3.2.3. Assay B 
In this assay, a layer of IPTES was added to the fluorescent Si QDs aiming the 
creation of a centered core, avoiding further delivery of the QDs through the pore. The 
addition of IPTES compound led to the formation of a white precipitate, followed by the 
change of color in the emission from green to blue, with a maximum band centered at ca. 
439 nm. After that, a layer of MSNs was added by two different methods, as can be seen in 
the experimental part, via i (3.1.2.3.2.1.) and via ii (3.1.2.3.2.2.). The main results are 
gathered in Figure 3.9. 
(C)(B)
(D)
Size (nm) / PDI Zeta Potential (mV) ΦF (%)

















Figure 3.9 – Solid-state fluorescence emission spectra of (A) SiQDs@Isoc, (B) SiQDs@Isoc@mSiO2 
(T1-T4), (D) T3@PEG3 (λexc = 370 nm). Inset A, D: (I, P) Naked eye and (I*, P*) under UV irradiation 
(λexc = 365 nm) SiQDs@Isoc and T3@PEG3 photographs, respectively. (C) (T1-T4) Naked eye and 
(T1*-T4*) under UV irradiation (λexc = 365 nm) SiQDs@Isoc@mSiO2 (T1-T4) photographs. (E) 
Infrared spectrum of SiQDs@Isoc@mSiO2 (T1-T4) and PEGylated SiQDs@Isoc@mSiO2 (T3@PEG3). 
(F) Size, PDI and zeta potential values of SiQDs@Isoc@mSiO2 (T1-T4) and SiQDs@Isoc@mSiO2 (T3) 
functionalized with PEG3 (T3@PEG3) (solvent: water). (without template) 
 
Functionalization with IPTES leads to the formation of bigger nanoparticles with a 
hydrodynamic size around 458 nm. 
As mentioned above, a layer of MSNs was added through two different methods, 
via i and ii, and in each via, two distant sources of silane were tested: TEOS (T1, T3) and 
TMOS (T2, T4). All the resulting nanoparticles have a white color with emission bands 
centered at ca. 440-450 nm, shifting just a few nanometers from the initial SiQDs@Isoc. 
Moreover, a total inversion of the zeta potential is visualized, obtaining all nanoparticles T1 
to T4 similar values of ca. 30 mV. Besides the very stable results in the zeta potential, the 













































































Size (nm) / PDI Zeta Potential (mV)
T1 1275 / 0.66 29.20
T2 807.3 / 0.30 32.37
T3 626.2 / 0.87 28.97
T3@PEG3 1291 / 0.50 34.80
T4 1055 / 0.72 29.03
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Through TEM images, were observed that the best samples were the T3, thus to improve its 
solubility and reduce aggregation, T3 was functionalized with the polymer PEG3, and as a 
result, improvements in the PDI (from ca. 0.9 to 0.5) and zeta potential (from ca. 29 mV to 
35 mV) were evidenced. Additionally, a blue shift from 450 nm to 436 nm in the emission 
spectra after PEG functionalization indicates the surface coating of the nanoparticles.  
All synthetic steps were followed by infrared technique, and according to the IR 
spectra (Figure 3.9 – E), a typical band of the silica framework at 1070 cm-1 (Si-O-Si) was 
detected. Moreover, the absorption peak at 692.41 cm-1 can be attributed to the Si-C 
stretching vibration. Additionally, in T1, T2 and T3 a broad band at 3600-3100 cm-1 is 
associated with absorbed water, and the vibration at ca. 1635 cm-1 in all nanoparticles, 
indicates the bending modes of physisorbed water. The peak at 1740 cm-1 confirms the layer 
of isocyanate (C=O), as well as, the peaks at ca. 1565 cm-1 of NH vibration the 
functionalization of the PEG polymer. The vibration –(CH2CH2)n is observed at ca.                  
2974-2874 cm-1 and ca. 1443 cm-1, respectively. The additional increment in the mode at ca. 
1368 cm-1 indicates the deformation vibrations of the polymer backbone (CH). Moreover, 
an additional absorption peak at ca. 1200 cm-1 can be attributed to the C-N stretching 
vibration of the polymer. 
The morphology of all the nanoparticles was confirmed through TEM and SEM 
images, where sample T3 presented the best results (see Figure 3.10). TEM and SEM images 
proved the spherical shape of the nanoparticles, as well as their pore in Figure 3.10 – C, 
represented by the white dots. Through TEM and SEM images, were noticed that T3 
nanoparticles have a size around 114 ± 17 nm and ca. 139 ± 18 nm, respectively. Moreover, 
through the SEM images is possible to observe the size decrease/aggregation of the 
nanoparticles after functionalization with PEG3, changing from 139 nm to 128 nm. 
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Figure 3.10 – (A-C) TEM images of SiQDs@Isoc@mSiO2 (T3). (D) SEM image of SiQDs@Isoc@mSiO2 
(T3) and (E) of SiQDs@Isoc@mSiO2@PEG3 (T3@PEG3). The inset images show the corresponding 
size distribution. 
 
3.2.3.1. Encapsulation studies on SiQDs@Isoc@mSiO2 (T3) and PEGylated 
SiQDs@Isoc@mSiO2 (T3@PEG3) 
Encapsulation studies of the blue MSNs T3 and T3@PEG3 in physiological pH (PBS, 
pH = 7.4) with single proteins exhibiting different sizes and pI, such as BSA, LYS, CYT, Myb, 
Hb, CA and OVA were accomplished. These proteins were selected due to the wide variety 
of physical properties they collectively presented (Table 3.3 and Table A.1 - Appendix).  
 The proteins were incubated with the nanoparticles in PBS, with a weight ratio of 
1:4 (protein:MSNs) for incubation times of 30 min. EE and the amount adsorbed were 
determined accordingly with section 3.1.3. in the experimental part, and the obtained 




























































sA = 114  17 nm
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Table 3.3 – List of encapsulated proteins and their properties. aGeometric dimensions given by 
published literature [96,97]. bThe residue count of these proteins come from the Protein Data Bank. 
PDB codes: BSA, 3V03; LYS, 1DPX; CYT, 1HRC; Myb, 1WLA; Hb, 1A3N; CA, 1V9E; OVA, 1OVA. 
 
 
Figure 3.11 – Encapsulation efficiency (EE%) and corresponding loading capacity (mg/g) of several 
proteins with SiQDs@Isoc@mSiO2 (T3) and PEGylated SiQDs@Isoc@mSiO2 (T3@PEG3), weight ratio 
of 1:4 (protein:MSNs) in PBS pH = 7.4.  
 
A common tendency is observed for all proteins where they are encapsulated 
within the nanoparticles. The T3 and T3@PEG3 nanoparticles are positively charged, so it 
should be expected a higher affinity towards the negatively charged proteins, like BSA, CA 
and OVA. As a matter of fact, no significant changes were observed in all proteins, with EE 
around 50%, with the exception of CA that presents a value of 30%. The loading capability 
is around 100-120 mg/g of nanoparticles. Moreover, the addition of PEG slightly decreases 
the affinity of the nanoparticles to the proteins.  
Considering the initial weight ratio between the proteins and MSNs (1:4), and the 
EE, these results showed that these nanoparticles could act as nanocarriers to efficiently 
encapsulate a wide variety of proteins. 





Bovine Serum Albumin (BSA) 69293 5 x 5 x 9 4.9 6.6 22.7
Lysozyme (LYS) 16239 3 x 3 x 4.5 10–10.5 4.8 28.6
Cytochrome C (CYT) 11833 2.6 x 3.2 x 3.3 11.35 2.9 23.8
Myoglobin (Myb) 17083 ca. 17.6 6.8-7.2 5.2 16.2
Hemoglobin (Hb) 15998 5.3 x 5.4 x 6.5 6.8 4.8 13.6
Carbonic Anhydrase (CA) 28822 3.9 x 4.2 x 5.5 5.9 5.7 16.1
















BSA LYS CYT Myb Hb CA OVA
T3 - EE (%) 30 min.
T3@PEG3 - EE (%) 30 min.
T3 - Loading capacity (mg/g) 30 min.























3.2.4. Assay C 
Concerning assay C, to the crude green Si QDs in 3.1.2.2.3. ES, a layer of MSNs was 
added through the method via ii (3.1.2.3.2.2.) described in the experimental part., however 
with a TEOS optimization to 1 mL instead of 500 µL. Furthermore, the previous layer was 
functionalized with two different PEG polymers, as can be seen in ES, C1 (3.1.2.4.2.1.) and 
C2 (3.1.2.4.2.2.). The main results are presented in Figure 3.12.  
 
Figure 3.12 – Solid-state fluorescence emission spectra of (A) SiQDs@mSiO2, (D) 
SiQDs@mSiO2@PEG2 (C1) and SiQDs@mSiO2@PEG3 (C2) (λexc = 370 nm). Inset A: (C) Naked eye and 
(C*) under UV irradiation (exc = 365 nm) SiQDs@mSiO2 powder photographs. (B) Naked eye and (C) 
under UV irradiation (exc = 365 nm) SiQDs@mSiO2 photographs. (C1-C2) Naked eye and (C1*-C2*) 
under UV irradiation (exc = 365 nm) SiQDs@mSiO2@PEG2 (C1) and SiQDs@mSiO2@PEG3 (C2) 
photographs, respectively. (E) The infrared spectrum of SiQDs@mSiO2 and PEGylated SiQDs@mSiO2 
(C1 and C2). (F) Size, PDI and zeta potential values of SiQDs@mSiO2 and PEGylated SiQDs@mSiO2 
(C1 and C2) (solvent: water). (without template) 
 
Addition of the layer of MSNs originates a change in color, from green to blue, with 
a maximum band centered at ca. 472 nm. Moreover, this addition leads to a formation of 
bigger nanoparticles with a hydrodynamic size around 386 nm, and a total inversion of the 
zeta potential to positive values with ca. 29 mV, was also observed. However, there was an 
increment in the PDI, which resulted in poor solubility of the nanoparticles in water. To 

















































Size (nm) / PDI Zeta Potential (mV)
SiQDs@mSiO2 386.0 / 0.55 29.00
SiQDs@mSiO2@PEG2 (C1) 710.4 / 0.61 33.60

















and PEG3, with different sizes. There was an improvement in the PDI (from ca. 0.6 to 0.3) in 
C2 with PEG3, yet it is not possible to evidence the same result for C1 with PEG2, which 
maintained the same PDI. On the other hand, a slight increase of the zeta potential (from             
29 mV to 33.6 mV) in C1 was also visualized, unlike C2. Also, a blue shift (from 472 nm to 
468 nm) and a red shift (from 472 nm to 492 nm) in the emission spectra after PEG2 and 
PEG3 functionalization, respectively, indicates the surface coating of the nanoparticles. 
Infrared spectra of the nanoparticles (Figure 3.12 – E) was performed to confirm 
the chemical binding of the products. A typical band of the silica framework at 1022 cm-1 
(Si-O-Si) was observed. Additionally, the vibration at ca. 1535 cm-1 and 1630 cm-1, 
correspond to NH polymer (C2) and the bending modes of physisorbed water, respectively. 
In C8 the –(CH2CH2)n vibration is observed at ca. 3019-2947 cm-1 and ca. 1444 cm-1. An 
additional mode at ca. 1367 cm-1 (CH) indicates the deformation vibrations of the polymer 
backbone. 
The morphology of the nanoparticles was confirmed through SEM images where 
sample C2 presented the best results (see Figure 3.13). Through SEM images the spherical 
shape of the nanoparticles was proved, and it was also possible to observe the size 
decrease/aggregation of the nanoparticles after functionalization with PEG3, with a size 
around 44 ± 6 nm. 
 
Figure 3.13 – SEM images of SiQDs@mSiO2@PEG3 (C2). The inset image shows the corresponding 
size distribution. 
 
3.2.4.1. Encapsulation studies on SiQDs@mSiO2 and PEGylated SiQDs@mSiO2 
(C1 and C2) 
Encapsulation studies of the blue MSNs SiQDs@mSiO2, C1 and C2 in physiological 
pH (PBS, pH = 7.4) with single proteins exhibiting different sizes and pI, such as BSA, LYS, 
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variety of physical properties they collectively presented (Table 3.3 and Table A.1 - 
Appendix). The proteins were incubated with the nanoparticles in PBS, with a weight ratio 
of 1:4 (protein:MSNs) for incubation times of 30 min. EE and the amount adsorbed were 
determined accordingly with section 3.1.3. in the experimental part, and the obtained 
results are gathered in Figure 3.14. 
 
Figure 3.14 – Encapsulation efficiency (EE%) and corresponding loading capacity (mg/g) of several 
proteins with SiQDs@mSiO2 and PEGylated SiQDs@mSiO2 (C1 and C2), weight ratio of 1:4 
(protein:MSNs) in PBS = 7.4.  
 
It was possible to visualize a similar behavior between the samples SiQDs@mSiO2 
and C1. Both presented a higher affinity towards the negatively charged proteins CA and 
OVA, as expected since these nanoparticles are positively charged, thereby having a less 
affinity towards CYT and Hb proteins, with a decrease around 60% of EE and 100 mg/g of 
loading capacity. On the other hand, the addition of PEG3 increased the affinity toward BSA 
and Hb, reducing then its affinity to Myb. 
 
3.2.5. Assay D 
In this assay, to the crude green fluorescent Si QDs in 3.1.2.2.3. ES, was added a 
layer of IPTES with the same purpose of assay B, to avoid the QDs delivery through the pore 
of the MSNs. Similar as in assay B, a white precipitate was created after the addition of 
IPTES, followed by the change of color in the emission from green to blue, in this case with 
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by via ii (3.1.2.3.2.2.) described in the experimental part. The predominant results are in 
Figure 3.15. 
 
Figure 3.15 – Solid-state fluorescence emission spectra of (A) SiQDs@Isoc, (B) SiQDs@Isoc@mSiO2 
and (C) PEGylated SiQDs@Isoc@mSiO2 (D1@PEG3) (λexc = 370 nm). Inset A, B, C: (B, D1, P) Naked 
eye and (B*, D1*, P*) under UV irradiation (exc = 365 nm) photographs of SiQDs@Isoc, 
SiQDs@Isoc@mSiO2 (D1) and PEGylated SiQDs@Isoc@mSiO2 (D1@PEG3), respectively. (D) Infrared 
spectrum of SiQDs@Isoc@mSiO2 (D1) and PEGylated SiQDs@Isoc@mSiO2 (D1@PEG3). (E) Size, PDI 
and zeta potential values of SiQDs@Isoc@mSiO2 (D1) and PEGylated SiQDs@Isoc@mSiO2 
(D1@PEG3) (solvent: water). (without template) 
 
As expected in comparison with assay B, the functionalization of the Si QDs with 
IPTES increased the hydrodynamic size of the nanoparticles, in this case to around 645 nm. 
The same happened with the addition of the mesoporous silica layer to around 2404 nm. 
The resulting nanoparticles have a maximum band centered at 450 nm, and it was possible 









































































Size (nm) / PDI Zeta Potential (mV)
SiQDs@Isoc 645.2 / 0.73 29.43
SiQDs@Isoc@mSiO2 (D1) 2404 / 0.48 35.57
D1@PEG3 4423 / 0.20 34.13
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the surface coating and stability. However, there were still improvements to be done 
regarding the solubility of the nanoparticles, which can be visualized by the high PDI of ca. 
0.5. For this reason, PEG3 was added to the luminescent MSNs to increase its solubility, and 
results were evidenced by a decrease in the PDI from ca. 0.5 to 0.2. 
The infrared spectra (Figure 3.15 – D) showed similar peaks described for the 
similar system in Assay B.  
To confirm the morphology of the mesoporous nanoparticles, the PEGylated 
SiQDs@Isoc@mSiO2 (D1@PEG3) was analyzed by SEM and the images are depicted in 
Figure 3.16. The PEGylated nanoparticles are quite aggregated but are spherical, with a size 
around 46 ± 11 nm. 
 
Figure 3.16 – SEM images of PEGylated SiQDs@Isoc@mSiO2 (D1@PEG3). The inset image shows the 
corresponding size distribution. 
 
3.3. CONCLUSIONS 
In summary, fluorescent Si QDs coated with a monolayer of MSNs have been 
successfully obtained with good dispersions in water, through the introduction of PEG 
derivatives. Several techniques were applied to characterize the SiQDS@mSiO2 and 
PEGylated nanoparticles. As a proof-of-concept, in the first assay (Assay A) experiments 
proved that the syntheses were successfully carried out, nevertheless some modifications 
must be taken in consideration in order to decrease the size, improve the shape and 
decrease aggregation. From this point, several modifications concerning the synthesis of Si 
QDs and their further coating with MSNs were optimized (Assays B-D). 
Based on such results, the introduction of a layer of IPTES to the green fluorescent 
Si QDs (Assay B and D) aiming the creation of a centered core, proved to avoid further 
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nanoparticles. Moreover, a total inversion of the zeta potential to positive values of ca.            
30 mV, was obtained for all nanoparticles in Assay B to D, confirming the surface coating 
and improvement of stability. TEM and SEM images proved the spherical shape of the 
nanoparticles. Moreover, through SEM image was possible to observe the size 
decrease/aggregation of the nanoparticles after functionalization with PEG. Regarding the 
encapsulation studies, all the resulting nanoparticles in Assay B and C are positive charged, 
so it should be expected a higher affinity towards the negatively charged proteins, like BSA, 
CA and OVA. However, in Assay B no significant changes were observed, showing a common 
tendency for all nanoparticles. On the other hand, in Assay C this observation was 
demonstrated where both un-PEGylated and PEGylated nanoparticles presented a higher 
affinity towards CA and OVA, and as expected a less affinity towards CYT and Hb proteins. 
The nanoparticles functionalized with PEG3 demonstrated a different behavior with an 
increase of affinity towards BSA and Hb, reducing its affinity to Myb. 
To sum up, considering these results it is clearly shown that a promising 
biocompatible and biodegradable system was created. These nanoparticles can also act as 















Herein we will focus on the synthesis and characterization of PEG-derivatives and 
their further application on the functionalization of MSNs surface to increase the solubility 
of these systems in water. PEG-derivatives were synthesized and optimized according to 
what was necessary to perform the synthesis. 
KEYWORDS: PEG, PEG-Silane derivatives, 1H NMR, Infrared spectroscopy. 
 
4.1. EXPERIMENTAL SECTION 
4.1.1. Reagents and Chemicals: 
Poly(ethylene glycol) BioUltra 3000, poly(ethylene glycol) BioUltra 6000, 
poly(ethylene glycol) BioUltra 8000, p-toluenesulfonyl chloride (CH3C6H4SO2Cl, ≥98%), 
hydrochloric acid (HCl, 37%), Magnesium sulfate (MgSO4, ≥99.5%),                                                                 
(3-aminopropyl)trimethoxysilane (APTMS, H2N(CH2)3Si(OCH3)3, 97%) and                                    
(3-aminopropyl)triethoxysilane (APTES, H2N(CH2)3Si(OC2H5)3, 99%) were all purchased 
from Sigma-Aldrich. Sodium hydroxide (NaOH) was produced by Panreac. Tetrahydrofuran 
(THF, C4H8O, ≥99.9%) was purchased from Carlo Erba Reagents. Chloroform (CHCl3) was 
produced by Merck. All the reagents and solvents were of analytical reagent grade and were 
used as received. 
 
4.1.2. Syntheses: 
4.1.2.1. Synthesis of PEG(3000)-Silane (PEG1) 




























in a round-bottom flask. Then 1.8 g (0.6 mmol) of the commercially available poly(ethylene 
glycol) BioUltra 3000 (PEG3000) in 10 mL THF was added to the previous solution. The 
resulting mixture was stirred for 1 h at 0°C. Then 0.137 g (0.72 mmol) of p-toluenesulfonyl 
chloride in 1 mL of THF was added dropwise to the reaction mixture during 30 min at 0°C. 
The mixture was stirred for an additional 3 h. After that, a solution of 1 M HCl (2 mL) was 
added, and the organic phase was extracted three times with chloroform, dried over MgSO4, 
filtered and the solvent was removed by rotary evaporation. The transparent crude product, 
showing the substitution of the terminal –OH group with –OTs, was used for the next step 
without further purification [64]. 
To the product was added 0.140 mL (0.6 mmol) of APTES in 2.5 mL chloroform 
and left at 70°C for 8 h under reflux conditions, to bind the silane group to the PEG-OTs 
moiety through the amino functionality. The organic solvent was removed by rotary 
evaporation and the obtained raw product was stored at 4°C (Scheme 4.1 and 4.2) [64]. 
1H-NMR (CDCl3): 3.83 (q, Si(OCH2CH3)3), 3.71–3.58 (m, (OCH2CH2)3000), 3.46              
(t, CH2CH2NH), 0.86 (m, CH2Si).  
 
Scheme 4.1– Synthesis of PEG1. 
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Scheme 4.2 – Procedure applied in the synthesis of PEG1. 
 
4.1.2.2. Synthesis of TsO-PEG-Silane 
4.1.2.2.1. Synthesis of TsO-PEG(6000)-Silane (PEG2) 
It was performed the same procedure previously described in 4.1.2.1., however 
using different equivalents.  
A solution of 240 mg (6.0 mmol) NaOH in 10 mL of bi-distilled water was prepared 
in a round-bottom flask. Then 10 g (1.67 mmol) of the commercially available poly(ethylene 
glycol) BioUltra 6000 in 20 mL THF was added to the previous solution. The resulting 
mixture was stirred for 1 h at 0°C. Then 1.093 g (5.73 mmol) of p-toluenesulfonyl chloride 
in 1 mL of THF was added dropwise to the reaction mixture during 30 min at 0°C. The 
mixture was stirred for an additional 3 h. After that a solution of 1 M HCl (10 mL) was added, 
and the organic phase was extracted three times with chloroform, dried over MgSO4, filtered 
and the solvent was removed by rotary evaporation. The transparent crude product, 
showing the substitution of the terminal –OH group with –OTs, was used for the next step 
without further purification. 
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115 μL (0.49 mmol, 1eq) of APTES in 2 mL chloroform was added                                   
TsO-PEG(6000)-OTs dissolved in 10 mL of chloroform and stirred at 70°C for 8 h under 
reflux conditions, to bind the silane group to the PEG-OTs moiety through the amino 
functionality. The organic solvent was removed by rotary evaporation and the obtained raw 
product was stored at 4°C (Scheme 4.3).  
1H-NMR (CDCl3): 7.95 (d, ring CH, –SO3 side), 7.82 (d, ring CH, CH3- side), 3.84        
(q, Si(OCH2CH3)3), 3.71–3.58 (m, (OCH2CH2)6000), 3.49 (t, (OCH2CH2)6000OCH2), 2.49                  
(d, CH2NH), 2.37 (t, NHCH2), 1.84 (s, CH3 tosyl), 1.65 (m, NHCH2CH2), 1.27                                           




4.1.2.2.2. Synthesis of TsO-PEG(8000)-Silane (PEG3) 
The same procedure described in section 4.1.2.2.1. was performed; however, it 
was used a solution of 180 mg (4.5 mmol) NaOH in 8.33 mL of bi-distilled water. Then 10 g                    
(1.25 mmol) of the commercially available poly(ethylene glycol) BioUltra 8000,  0.9342 g 
(4.9 mmol) of p-toluenesulfonyl chloride in 1 mL of THF and 130 μL (0.73 mmol, 1 eq) of 
APTMS in 2 mL chloroform was added to 6.061 g (0.73 mmol, 1eq) of TsO-PEG(8000)-OTs 
(Scheme 4.4). 
1H-NMR (CDCl3): 7.95 (d, ring CH, –SO3 side), 7.82 (d, ring CH, CH3- side),              
3.71–3.58 (m, (OCH2CH2)8000), 3.49 (m, (OCH2CH2)8000OCH2), 2.50 (d, CH2NH), 2.37                       
(t, NHCH2), 1.79 (s, CH3 tosyl), 1.65 (m, NHCH2CH2), 1.28 (m, Si(OCH3)3), 0.90 (t, CH2Si). 
 
 
Scheme 4.3 – Synthesis of PEG2.  




Infrared spectra were recorded on a PerkinElmer BX or PerkinElmer Spectrum Two 
spectrometer. 1H NMR spectra were recorded on a Bruker Avance III 400 at FCT-University 
Nova of Lisbon, Portugal. The NMR spectrometers are part of The National NMR Facility, 
supported by Fundação para a Ciência e a Tecnologia (RECI/BBB-BQB/0230/2012). 
 
 
4.2. RESULTS AND DISCUSSION  
Aiming an improvement of water solubility of the different nanoparticles 
described in Chapter 2 and 3, PEG-derivatives were needed to be synthetized following the 
method reported by Cauda and co-workers [64]. Specifically, three types of PEG-derivatives 
were synthesized, having three different PEG-chain lengths with (i) Mw 3000, (ii) Mw 6000, 
and (iii) Mw 8000. Briefly, PEG-derivatives were obtained by first preparing an intermediate 
leaving group, poly(ethylene glycol) tosylate, being further combined with two different 
sources of silica, as can be seen in the experimental part, APTES in 4.1.2.1. and 4.1.2.2.1., and 
APTMS in 4.1.2.2.2., to create the linear PEG-Silanes with different lengths.   
PEG was converted to bitosyl-PEG which reacted with APTES or APTMS to obtain 
the linear PEG-Silane. The structures of PEG1, PEG2 and PEG3 compared with PEG3000 
were identified by 1H NMR analysis, Figure 4.1. 
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Figure 4.1 – 1H NMR (400 MHz) spectra of PEG3000, PEG1, PEG2, and PEG3. 
 
The chemical shifts for protons from position 1 to 4 in the PEG3000, from 1 to 10 
in the PEG1, from 1 to 15 in the PEG2, and from 1 to 14 in the PEG3 are shown in the previous 
figure (the expansions of the undistinguished spectra peaks at regular scale are shown in 
the Appendix, section A.2.3.). The molecular structure of the different PEG-derivatives was 
confirmed by the presence of all the characteristic peaks and peak integration. 
To further verify the successful synthesis of the PEG-derivatives, infrared spectra 




























Figure 4.2 – Infrared spectra of PEG3000, PEG1, PEG2 and PEG3. 
Regarding the infrared spectra in Figure 4.2, all PEG-derivatives show the 
characteristic peaks at 2880 cm-1, 1466 cm-1 and 1097-1105 cm-1 related to the vibration      
–(CH2CH2)n and C-O ether bending vibration of the polymer. Moreover, the bending 
vibration of the benzene ring at 748-752 cm-1 in PEG1-3 also indicate that PEG had reacted 
with the TsCl. 
 
4.3. CONCLUSIONS 
In summary, three different types of PEG-derivatives have been successfully 
obtained, and in addition, it allowed to acquire good dispersions in water through the 
functionalization of these PEG-derivatives in luminescent MSNs, as it was possible to verify 
in the previous Chapters 2 and 3. Different techniques were applied to characterize these 
PEG-derivatives, such as FT-IR and NMR, which proved the introduction of the terminal 
group OTs, that were further combined with a source of silica, such as APTES or APTMS, 
creating the linear PEG-Silane. Due to these results, it is possible to conclude that with this 
inexpensive technique, large quantities of silane-modified PEG can be obtained, which can 
be used to covalently attach to MSNs or other surfaces, creating a system with possible 



































The use of biodegradable luminescent inorganic MSNs as a therapeutic tool 
promises an evolution in drug delivery and protein loading/extraction, as well as a major 
advantage the use of environmentally friendly nano-tools. Regarding such aspect, the 
synthesis and characterization of luminescent inorganic mesoporous nanomaterials 
(QDs@mSiO2), and their further application for protein loading/extraction were explored.  
In summary, fluorescent QDs coated with MSNs have been successfully obtained, 
and improvements in water solubility were observed with the functionalization of PEG-
derivatives into the mesoporous surface. Several techniques were performed to 
characterize the different nanoparticles. 
On Chapter 2 experiments proved that photo-stability of the CdTe QDs was 
improved by MSNs coating. Also, Green CdTeQDs@mSiO2 and CdTeQDs@mSiO2@PEG1 
have demonstrated a large affinity for proteins, such as Hb, CA and OVA. 
As for Chapter 3 after several modifications,  concerning the synthesis of the Si QDs 
and their further coating with MSNs, there was an improvement of stability after a total 
inversion of the zeta potential. Further experiments led to discover that the introduction of 
a layer of IPTES can decrease post-delivery of the QDs through the mesoporous pore. All 
nanoparticles are positively charged and encapsulation studies demonstrated a common 
tendency to encapsulate all proteins, with the exception of Assay C presenting a different 
behavior towards specific proteins, where SiQDs@mSiO2 and C1 present a higher affinity 
towards the negatively charged proteins CA and OVA, with a decrease towards CYT and Hb 
proteins. And also, C2 with an increase of affinity towards BSA and Hb, reducing its affinity 
to Myb.  
In common with Chapter 2 and 3, TEM and SEM images proved the spherical shape 
of the nanoparticles. Moreover, the size decrease/aggregation of the nanoparticles after 


























Concerning Chapter 4, the synthesis of three different types of PEG-derivatives was 
successfully carried out. PEG-derivatives were obtained using a two-step synthesis where 
firstly was prepared an intermediate leaving group with a terminal group OTs and then 
further combined with APTES or APTMS by heating at 70°C for 8 h, as confirmed by FT-IR 
and NMR. Through this method large quantities of silane-modified PEG were obtained using 
an inexpensive, straightforward technique, which can be used to attach PEG to MSNs or 
other surfaces covalently. The preparation of these different PEG-silane polymers allowed 
to synthesize luminescent MSNs with high colloidal stability in aqueous solutions, making 
them suitable for several biological applications. 
To sum up, there are still some improvements to be made regarding the decrease 
of aggregation and water solubility, yet these systems proved to be promising nanocarriers 








[1] Z. Li, Q. Sun, Y. Zhu, B. Tan, Z. P. Xu, and S. X. Dou, “Ultra-small fluorescent inorganic 
nanoparticles for bioimaging,” J. Mater. Chem. B, vol. 2, no. 19, p. 2793, 2014. 
[2] W. C. Chan, “Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection,” 
Science (80-. )., vol. 281, no. 5385, pp. 2016–2018, 1998. 
[3] M. Bruchez Jr., “Semiconductor Nanocrystals as Fluorescent Biological Labels,” 
Science (80-. )., vol. 281, no. 5385, pp. 2013–2016, 1998. 
[4] M. F. Frasco and N. Chaniotakis, “Semiconductor quantum dots in chemical sensors 
and biosensors,” Sensors, vol. 9, no. 9, pp. 7266–7286, 2009. 
[5] S. J. Byrne et al., “Optimisation of the synthesis and modification of CdTe quantum 
dots for enhanced live cell imaging,” J. Mater. Chem., vol. 16, no. 28, p. 2896, 2006. 
[6] H. Bao, Y. Gong, Z. Li, and M. Gao, “Enhancement Effect of Illumination on the 
Photoluminescence of Water-Soluble CdTe Nanocrystals : Toward Highly 
Fluorescent CdTe / CdS Core - Shell Structure,” Chem. Mater., vol. 16, no. 15, pp. 
3853–3859, 2004. 
[7] C. Wang, H. Zhang, J. Zhang, M. Li, H. Sun, and B. Yang, “Application of ultrasonic 
irradiation in aqueous synthesis of highly fluorescent CdTe/CdS core-shell 
nanocrystals,” J. Phys. Chem. C, vol. 111, pp. 2465–2469, 2007. 
[8] L. Li et al., “Rapid synthesis of highly luminescent CdTe nanocrystals in the aqueous 
phase by microwave irradiation with controllable temperature,” Chem. Commun., vol. 
281, no. 4, p. 528, 2005. 
[9] Y. He et al., “Microwave-assisted synthesis of water-dispersed CdTe nanocrystals 
with high luminescent efficiency and narrow size distribution,” Chem. Mater., vol. 19, 
no. 3, pp. 359–365, 2007. 
[10] H. Zhang, L. Wang, H. Xiong, L. Hu, B. Yang, and W. Li, “Hydrothermal Synthesis for 
High-Quality CDTe Nanocrystals,” Adv. Mater., vol. 15, no. 20, pp. 1712–1715, 2003. 
[11] S. Wu, J. Dou, J. Zhang, and S. Zhang, “A simple and economical one-pot method to 
synthesize high-quality water soluble CdTe QDs,” J. Mater. Chem., vol. 22, no. 29, p. 
14573, 2012. 
[12] A. M. Derfus, W. C. W. Chan, and S. N. Bhatia, “Probing the Cytotoxicity of 
Semiconductor Quantum Dots, Supp. Info.,” Nano Lett., vol. 4, no. 1, pp. 11–18, 2004. 
[13] C. Kirchner et al., “Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles,” Nano 
Lett., vol. 5, no. 2, pp. 331–338, 2005. 
[14] Y. Yu, C. E. Rowland, R. D. Schaller, and B. A. Korgel, “Synthesis and Ligand Exchange 
of Thiol-Capped Silicon Nanocrystals,” Langmuir, vol. 31, no. 24, pp. 6886–6893, 
66 
2015. 
[15] C. Song et al., “Peptide-Conjugated Fluorescent Silicon Nanoparticles Enabling 
Simultaneous Tracking and Specific Destruction of Cancer Cells,” Anal. Chem., vol. 87, 
no. 13, pp. 6718–6723, 2015. 
[16] J. M. J. Paulusse, M. W. F. Nielen, and H. Zuilhof, “Preparation, Characterization, and 
Surface Modi fi cation of Tri fl uoroethyl Ester-Terminated Silicon Nanoparticles,” 
Am. Chem. Soc., vol. 24, p. 4311−4318, 2012. 
[17] J. L. Heinrich, C. L. Curtis, G. M. Credo, M. J. Sailor, and K. L. Kavanagh, “Luminescent 
colloidal silicon suspensions from porous silicon.,” Science, vol. 255, no. 5040, pp. 66–
68, 1992. 
[18] F. Hua, F. Erogbogbo, M. T. Swihart, and E. Ruckenstein, “Organically capped silicon 
nanoparticles with blue photoluminescence prepared by hydrosilylation followed by 
oxidation,” Langmuir, vol. 22, no. 9, pp. 4363–4370, 2006. 
[19] X. Li, Y. He, and M. T. Swihart, “Surface functionalization of silicon nanoparticles 
produced by laser-driven pyrolysis of silane followed by HF- HNO3 etching,” 
Langmuir, vol. 20, no. 11, pp. 4720–4727, 2004. 
[20] L. Mangolini, E. Thimsen, and U. Kortshagen, “High-Yield Plasma Synthesis of 
Luminescent Silicon Nanocrystals,” Nano, 2005. 
[21] J. P. Wilcoxon and G. a. Samara, “Tailorable, visible light emission from silicon 
nanocrystals,” Appl. Phys. Lett., vol. 74, no. 21, p. 3164, 1999. 
[22] Y. Zhong et al., “Large-scale aqueous synthesis of fluorescent and biocompatible 
silicon nanoparticles and their use as highly photostable biological probes,” J. Am. 
Chem. Soc., vol. 135, no. 22, pp. 8350–8356, 2013. 
[23] Y. Zhong et al., “Facile, Large-Quantity Synthesis of Stable, Tunable-Color Silicon 
Nanoparticles and Their Application for Long-Term Cellular Imaging,” ACS Nano, vol. 
9, no. 6, pp. 5958–5967, 2015. 
[24] Q. Li et al., “Surface-modified silicon nanoparticles with ultrabright 
photoluminescence and single-exponential decay for nanoscale fluorescence lifetime 
imaging of temperature,” J. Am. Chem. Soc., vol. 135, no. 40, pp. 14924–14927, 2013. 
[25] J. Wang, D.-X. Ye, G.-H. Liang, J. Chang, J.-L. Kong, and J.-Y. Chen, “One-step synthesis 
of water-dispersible silicon nanoparticles and their use in fluorescence lifetime 
imaging of living cells,” J. Mater. Chem. B, vol. 2, no. 27, p. 4338, 2014. 
[26] S. D. Ma, Y. L. Chen, J. Feng, J. J. Liu, X. W. Zuo, and X. G. Chen, “One-Step Synthesis of 
Water-Dispersible and Biocompatible Silicon Nanoparticles for Selective Heparin 
Sensing and Cell Imaging,” Anal. Chem., vol. 88, no. 21, pp. 10474–10481, 2016. 
[27] C. T. Kresge, M. E. Leonowicz, W. J. Roth, J. C. Vartuli, and J. S. Beck, “Ordered 
67 
mesoporous molecular sieves synthesized by a liquid-crystal template mechanism,” 
Nature, vol. 359, no. 6397, pp. 710–712, 1992. 
[28] J. S. Beck et al., “A New Family of Mesoporous Molecular Sieves Prepared with Liquid 
Cristal Templates,” J. Am. Chem. Soc., vol. 114, no. 14, pp. 10834–10843, 1992. 
[29] U. Ciesla and F. Schüth, “Ordered mesoporous materials,” Microporous Mesoporous 
Mater., vol. 27, no. 2, pp. 131–149, 1999. 
[30] C. D. Nunes, M. Pillinger, A. A. Valente, and I. S. Gonc, “Synthesis and Characterization 
of Methyltrioxorhenium ( VII ) Immobilized in Bipyridyl-Functionalized Mesoporous 
Silica,” Eur. J. Inorg. Chem., no. Vii, pp. 1100–1107, 2002. 
[31] X. Hu, P. Zrazhevskiy, and X. Gao, “Encapsulation of single quantum dots with 
mesoporous silica,” Ann. Biomed. Eng., vol. 37, no. 10, pp. 1960–1966, 2009. 
[32] T. Yanagisawa, T. Shimizu, K. Kuroda, and C. Kato, “The preparation of 
alkyltrimethylammonium-kanemite complexes and their conversion to microporous 
materials,” Bulletin of the Chemical Society of Japan, vol. 63, no. 4. pp. 988–992, 1990. 
[33] L. Zhou, C. Gao, X. Hu, and W. Xu, “One-pot large-scale synthesis of robust ultrafine 
silica-hybridized CdTe quantum dots,” ACS Appl. Mater. Interfaces, vol. 2, no. 4, pp. 
1211–1219, 2010. 
[34] Z. Xu, P. Deng, S. Tang, D. Kuang, F. Zhang, and J. Li, “Preparation of 2D molecularly 
imprinted materials based on mesoporous silicas via click reaction,” J. Mater. Chem. 
B, vol. 2, no. 47, pp. 8418–8426, 2014. 
[35] D. Li, X. He, Y. Chen, W. Li, and Y. Zhang, “Novel Hybrid Structure 
Silica/CdTe/Molecularly Imprinted Polymer: Synthesis, Specific Recognition, and 
Quantitative Fluorescence Detection of Bovine Hemoglobin,” ACS Appl. Mater. 
Interfaces, vol. 5, pp. 12609–12616, 2013. 
[36] A. Wolcott et al., “Silica-coated CdTe quantum dots functionalized with thiols for 
bioconjugation to IgG proteins,” J. Phys. Chem. B, vol. 110, no. 11, pp. 5779–5789, 
2006. 
[37] Y. Song, Y. Cao, P. Chen, Q. Zhao, and G. Shen, “Fabrication od mesoporous 
CdTe/ZnO@SiO2 core/shell nanostructures with tunable dual emission and 
ultrasensitive flourescence response to metal ions,” Chem. Mater., vol. 21, no. 68, pp. 
68–77, 2009. 
[38] X. Hu, P. Zrazhevskiy, and X. Gao, “Encapsulation of Single Quantum Dots with 
Mesoporous Silica,” Ann. Biomed. Eng., vol. 37, no. 10, pp. 1960–1966, 2010. 
[39] S. Zhou et al., “Mesoporous silica-coated quantum dots functionalized with folic acid 
for lung cancer cell imaging,” Anal. Methods, vol. 7, no. 22, pp. 9649–9654, 2015. 
[40] P. Wang, Y. Zhu, X. Yang, C. Li, and H. L. Du, “Synthesis of CdSe nanoparticles into the 
68 
pores of mesoporous silica microspheres,” Acta Mater., vol. 56, no. 5, pp. 1144–1150, 
2008. 
[41] J. Sha, C. Tong, H. Zhang, L. Feng, B. Liu, and C. L??, “CdTe QDs functionalized 
mesoporous silica nanoparticles loaded with conjugated polymers: A facile sensing 
platform for cupric (II) ion detection in water through FRET,” Dye. Pigment., vol. 113, 
pp. 102–109, 2015. 
[42] Y. Gao et al., “Decorating CdTe QD-embedded mesoporous silica nanospheres with 
Ag NPs to prevent bacteria invasion for enhanced anticounterfeit applications,” ACS 
Appl. Mater. Interfaces, vol. 7, no. 18, pp. 10022–10033, 2015. 
[43] J. C. Santos et al., “Stable CdTe nanocrystals grown in situ in thiol-modified MCM-41 
mesoporous silica: Control synthesis and electrochemical detection of Cu2+,” 
Microporous Mesoporous Mater., vol. 221, pp. 48–57, 2016. 
[44] D. R. Radu, C. Lai, K. Jeftinija, E. W. Rowe, S. Jeftinija, and V. S. Lin, “Communication A 
Polyamidoamine Dendrimer-Capped Mesoporous Silica Nanosphere-Based Gene 
Transfection Reagent A Polyamidoamine Dendrimer-Capped Mesoporous Silica 
Nanosphere-Based,” Communication, no. lane 2, pp. 13216–13217, 2004. 
[45] J. Liu, A. Stace-naughton, X. Jiang, and C. J. Brinker, “Porous Nanoparticle Supported 
Lipid Bilayers ( Protocells ) as Delivery Vehicles Porous Nanoparticle Supported 
Lipid Bilayers ( Protocells ) as Delivery,” pp. 1354–1355, 2009. 
[46] V. Cauda et al., “Colchicine-loaded lipid bilayer-coated 50 nm mesoporous 
nanoparticles efficiently induce microtubule depolymerization upon cell uptake,” 
Nano Lett., vol. 10, no. 7, pp. 2484–2492, 2010. 
[47] L. S. Wang et al., “Biofunctionalized phospholipid-capped mesoporous silica 
nanoshuttles for targeted drug delivery: Improved water suspensibility and 
decreased nonspecific protein binding,” ACS Nano, vol. 4, no. 8, pp. 4371–4379, 2010. 
[48] J. M. H. S. Zalipsky, Poly(ethyleneglycol): chemistry and biological applications, vol. 
680. 1997. 
[49] J. H. Lee, H. B. Lee, and J. D. Andrade, “Blood compatibility of polyethylene oxide 
surfaces,” Prog. Polym. Sci., vol. 20, no. 6, pp. 1043–1079, 1995. 
[50] V. Cauda, A. Schlossbauer, and T. Bein, “Bio-degradation study of colloidal 
mesoporous silica nanoparticles: Effect of surface functionalization with organo-
silanes and poly(ethylene glycol),” Microporous Mesoporous Mater., vol. 132, no. 1–2, 
pp. 60–71, 2010. 
[51] J. L. Texas and S. P. Texas, “Hyaluronic Acid-decorated PLGA-PEG Nanoparticles for 
Targeted Delivery of SN-38 to Ovarian Cancer . Hyaluronic Acid-decorated PLGA-PEG 
Nanoparticles for Targeted Delivery of SN-38 to Ovarian Cancer,” vol. 2434, no. JUNE, 
69 
pp. 2425–2434, 2013. 
[52] M. V Cleveland, D. P. Flavin, R. A. Ruben, R. M. Epstein, and G. E. Clark, “New 
polyethylene glycol laxative for treatment of constipation in adults: A randomized, 
double-blind, placebo-controlled study,” South. Med. J., vol. 94, no. 5, pp. 478–481, 
2001. 
[53] D. Oupicky, M. Ogris, K. a Howard, P. R. Dash, K. Ulbrich, and L. W. Seymour, 
“Importance of lateral and steric stabilization of polyelectrolyte gene delivery 
vectors for extended systemic circulation.,” Mol. Ther., vol. 5, no. 4, pp. 463–72, 2002. 
[54] K. Knop, R. Hoogenboom, D. Fischer, and U. S. Schubert, “Poly(ethylene glycol) in drug 
delivery: Pros and cons as well as potential alternatives,” Angew. Chemie - Int. Ed., vol. 
49, no. 36, pp. 6288–6308, 2010. 
[55] C. E. Astete and C. M. Sabliov, “Synthesis and characterization of PLGA 
nanoparticles.,” J. Biomater. Sci. Polym. Ed., vol. 17, no. 3, pp. 247–289, 2006. 
[56] M. Muthu, “Nanoparticles Based on PLGA and its Co-Polymer: An Overview,” Asian J. 
Pharm., vol. 3, no. December, pp. 266–273, 2009. 
[57] J. M. Lu et al., “Current advances in research and clinical applications of PLGA-based 
nanotechnology,” Expert Rev. Mol. Diagn., vol. 9, no. 4, pp. 325–341, 2009. 
[58] M. J. Roberts, M. D. Bentley, and J. M. Harris, “Chemistry for peptide and protein 
PEGylation.pdf,” Adv. Drug Deliv. Rev., vol. 54, no. 4, pp. 459–476, 2002. 
[59] J. M. Harris, “Journal of Macromolecular Science , Part C : Polymer Reviews 
LABORATORY SYNTHESIS OF POLYETHYLENE GLYCOL DERIVATIVES,” J. Macromol. 
Sci., no. April 2012, pp. 37–41, 2007. 
[60] Y. Akiyama, H. Otsuka, Y. Nagasaki, M. Kato, and K. Kataoka, “Selective Synthesis of 
Heterobifunctional Poly(ethylene glycol) Derivatives Containing Both Mercapto and 
Acetal Terminals,” Bioconjugate Chem, vol. 11, pp. 947–950, 2000. 
[61] J. Li and W. J. Kao, “Synthesis of polyethylene glycol (PEG) derivatives and PEGylated-
peptide biopolymer conjugates.,” Biomacromolecules, vol. 4, no. 4, pp. 1055–1067, 
2003. 
[62] L. R. Hirsch et al., “Nanoshell-mediated near-infrared thermal therapy of tumors 
under magnetic resonance guidance,” Proc. Natl. Acad. Sci., vol. 100, no. 23, pp. 
13549–13554, 2003. 
[63] A. Jayagopal, P. K. Russ, and F. R. Haselton, “Surface engineering of quantum dots for 
in vivo vascular imaging,” Bioconjug. Chem., vol. 18, no. 5, pp. 1424–1433, 2007. 
[64] V. Cauda, C. Argyo, and T. Bein, “Impact of different PEGylation patterns on the long-
term bio-stability of colloidal mesoporous silica nanoparticles,” J. Mater. Chem., vol. 
20, no. 39, p. 8693, 2010. 
70 
[65] R. Tian et al., “Selective extraction of peptides from human plasma by highly ordered 
mesoporous silica particles for peptidome analysis,” Angew. Chemie - Int. Ed., vol. 46, 
no. 6, pp. 962–965, 2007. 
[66] J. M. Kisler, G. W. Stevens, and A. J. O. Connor, “Adsorption of Proteins on Mesoporous 
Molecular Sieves,” Mater. Phys. Mech., vol. 4, pp. 89–93, 2001. 
[67] R. Tian, M. Ye, L. Hu, X. Li, and H. Zou, “Selective extraction of peptides in acidic human 
plasma by porous silica nanoparticles for peptidome analysis with 2-D LC-MS/MS,” 
J. Sep. Sci., vol. 30, no. 14, pp. 2204–2209, 2007. 
[68] P. Yang, S. Gai, and J. Lin, “Functionalized mesoporous silica materials for controlled 
drug delivery,” Chem. Soc. Rev., vol. 41, no. 9, p. 3679, 2012. 
[69] F. Tang, L. Li, and D. Chen, “Mesoporous silica nanoparticles: Synthesis, 
biocompatibility and drug delivery,” Adv. Mater., vol. 24, no. 12, pp. 1504–1534, 2012. 
[70] Q. He and J. Shi, “Mesoporous silica nanoparticle based nano drug delivery systems: 
synthesis, controlled drug release and delivery, pharmacokinetics and 
biocompatibility,” J. Mater. Chem., vol. 21, no. 16, p. 5845, 2011. 
[71] M. Manzano and M. Vallet-Regí, “New developments in ordered mesoporous 
materials for drug delivery,” J. Mater. Chem., vol. 20, no. 27, p. 5593, 2010. 
[72] J. Tu et al., “Mesoporous Silica Nanoparticles with Large Pores for the Encapsulation 
and Release of Proteins,” ACS Appl. Mater. Interfaces, vol. 8, no. 47, pp. 32211–32219, 
2016. 
[73] Y. S. Chaudhary, S. K. Manna, S. Mazumdar, and D. Khushalani, “Protein encapsulation 
into mesoporous silica hosts,” Microporous Mesoporous Mater., vol. 109, no. 1–3, pp. 
535–541, 2008. 
[74] Z. Li, J. C. Barnes, A. Bosoy, J. F. Stoddart, and J. I. Zink, “Mesoporous silica 
nanoparticles in biomedical applications,” Chem. Soc. Rev., vol. 41, no. 7, p. 2590, 
2012. 
[75] J. Lei, L. Wang, and J. Zhang, “Superbright multifluorescent core - Shell mesoporous 
nanospheres as trackable transport carrier for drug,” ACS Nano, vol. 5, no. 5, pp. 
3447–3455, 2011. 
[76] X. Kang et al., “Core-shell structured up-conversion luminescent and mesoporous 
NaYF4:Yb3+/Er3+@nSiO2@mSiO2 nanospheres as carriers for drug delivery,” J. 
Phys. Chem. C, vol. 115, no. 32, pp. 15801–15811, 2011. 
[77] S. L. Flegler, J. Heckman, and K. L. Klomparents, Scanning and Transmission Electron 
Microscopy - An Introduction. Oxford University Press, 1995. 
[78] V. Kazmiruk, Scanning Electron Microscopy. InTech, 2012. 
[79] D. B. Williams and C. B. Carter, Transmission Electron Microscopy: A Textbook for 
71 
Materials Science. Springer, 2009. 
[80] “Atomic world - TEM.” [Online]. Available: http://www.hk-
phy.org/atomic_world/tem/tem02_e.html. 
[81] “Scanning Electron Microscope,” 2017. [Online]. Available: 
http://imgarcade.com/scanning-electron-microscope.html. 
[82] “Electron Microscope Diagram Of A Scanning Electron Microscope Diagram.” 
[Online]. Available: http://picphotos.net/electron-microscope-diagram-of-a-
scanning-electron-microscope-diagram/. 
[83] H. P. Klug and L. E. Alexander, X-ray diffraction procedures for polycrystalline and 
amorphous materials, Second Edi. New York: Wiley, 1974. 
[84] J. Grebenkemper, “Powder X-ray Diffraction,” 2017. [Online]. Available: 
https://chem.libretexts.org/Core/Analytical_Chemistry/Instrumental_Analysis/Dif
fraction_Scattering_Techniques/Powder_X-ray_Diffraction. 
[85] P. C. Hiemenz and R. Rajagopalan, Principles of Colloid and Surface Chemistry, Third 
Edit. CRC Press, 1997. 
[86] D. J. Shaw, Introduction to colloid and surface chemistry. Butterworth-Heine-mann, 
1992. 
[87] SelectScience, “The Art of Particles,” 2017. [Online]. Available: 
http://www.selectscience.net/SelectScience-TV/Videos/the-art-of-
particles/?videoID=3363. 
[88] P. R. Griffiths and J. A. De Haseth, Fourier Transform Infrared Spectrometry. John 
Wiley & Sons, 2007. 
[89] “Spectrum Two FT-IR spectrometer.” [Online]. Available: 
http://www.perkinelmer.co.uk/product/spectrum-two-ft-ir-sp10-software-
l160000a. 
[90] J. D. Ingle and S. R. Crouch, Spectrochemical Analysis. Prentice Hall, 1988. 
[91] “V-630Bio UV-Vis Spectrophotometer from Jasco.” [Online]. Available: 
https://www.news-medical.net/V-630Bio-UV-Vis-Spectrophotometer-from-Jasco. 
[92] “Spectrofluorometer, Compact.” [Online]. Available: 
http://www.acalbfi.com/nl/Photonics/Spectroscopy/Grating-based-
spectrometer/p/Spectrofluorometer--Compact/0000002C51. 
[93] M. Bouchoucha, M. F. Côté, R. C-Gaudreault, M. A. Fortin, and F. Kleitz, “Size-
Controlled Functionalized Mesoporous Silica Nanoparticles for Tunable Drug 
Release and Enhanced Anti-Tumoral Activity,” Chem. Mater., vol. 28, no. 12, pp. 4243–
4258, 2016. 
[94] J. Olmsted, “Calorimetric determinations of absolute fluorescence quantum yields,” J. 
72 
Phys. Chem., vol. 83, no. 20, pp. 2581–2584, 1979. 
[95] F. L. Arbeloa, P. R. Ojeda, and I. L. Arbeloa, “Flourescence self-quenching of the 
molecular forms of Rhodamine B in aqueous and ethanolic solutions,” J. Lumin., vol. 
44, no. 1–2, pp. 105–112, 1989. 
[96]    S. P. Hudson et al., “Proteins in mesoporous silicates,” ACS Symp. Ser., vol. 986, 
pp. 49–60, 2008. 
[97]   A. E. Eriksson, T. A. Jones, and A. Liljas, “Refined structure of human carbonic 
anhydrase II at 2.0 A resolution.,” Proteins, vol. 4, no. 2, pp. 274–282, 1988. 
[98] R. E. Kellogg and R. G. Bennett, “Radiationless Intermolecular Energy Transfer. III. 



















In this section, a few complementary information regarding the main experimental 
results and analysis is presented. The following Appendix is divided in two main 
subdivisions: Experimental section (A.1.) and Experimental results (A.2.). 
A.1, Table A.1 – describes the amino acid composition of all the proteins used in 
the encapsulation studies concerning Chapter 2 and 3. It contains the total amount of 
residues, available side-chain amines that participate in electrostatic interactions with the 
nanoparticles, and the percentage of charged residues.  
A.2, Figures A.1 – A.5 – present supplementary Green CdTeQDs@mSiO2@PEG1 
TEM images acquired in Chapter 2.  
A.2, Figures A.6 – A.9 – exhibit additional Green CdTeQDs@mSiO2@PEG1 SEM 
images acquired in Chapter 2.  
A.2, Figures A.10 – A.13 – show the infrared spectra of SiQDs@mSiO2 I and II (with 
and without template) performed in Assay A, Chapter 3. These spectra allow the 
confirmation of the assignment described in the main discussion. 
A.2, Figures A.14 – A.17 – present T1 TEM images acquired in Assay B, Chapter 3. 
A.2, Figures A.18 – A.21 – present T2 TEM images collected in Assay B, Chapter 3. 
A.2, Figures A.22 – A.25 – gather additional TEM and SEM images of T3 performed 
in Assay B, Chapter 3. 
A.2, Figures A.26 – A.29 – exhibit T4 TEM images acquired in Assay B, Chapter 3. 
A.2, Figure A.30 – A.31 – show the 1H NMR (400 MHz) spectra expansions of the 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A.2. Experimental results  
A.2.1. Experimental results (Chapter 2) 







































A.2.2. Experimental results (Chapter 3) 
A.2.2.1. Assay A 
 
 
Figure A.10 - Infrared spectrum of SiQDsI@mSiO2 (without template). 
 
 



















































































A.2.3. Experimental results (Chapter 4) 
 
 


















Figure A.31 – 1H NMR (400 MHz) spectra of PEG1 (green), with expansion.  
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